<?xml version='1.0' encoding='UTF-8'?>
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="iso-abbrev">Nat Sci Sleep</journal-id>
      <journal-id journal-id-type="publisher-id">Nature and Science of Sleep</journal-id>
      <journal-title-group>
        <journal-title>Nature and Science of Sleep</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1179-1608</issn>
      <publisher>
        <publisher-name>Dove Medical Press</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">28331381</article-id>
      <article-id pub-id-type="pmc">5354540</article-id>
      <article-id pub-id-type="doi">10.2147/NSS.S120048</article-id>
      <article-id pub-id-type="publisher-id">nss-9-081</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Original Research</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Retrospective, nonrandomized controlled study on autoadjusting, dual-pressure positive airway pressure therapy for a consecutive series of complex insomnia disorder patients</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>Krakow</surname>
            <given-names>Barry</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-9-081">1</xref>
          <xref ref-type="aff" rid="af2-nss-9-081">2</xref>
          <xref ref-type="aff" rid="af3-nss-9-081">3</xref>
          <xref ref-type="corresp" rid="c1-nss-9-081"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>McIver</surname>
            <given-names>Natalia D</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-9-081">1</xref>
          <xref ref-type="aff" rid="af2-nss-9-081">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Ulibarri</surname>
            <given-names>Victor A</given-names>
          </name>
          <xref ref-type="aff" rid="af1-nss-9-081">1</xref>
          <xref ref-type="aff" rid="af2-nss-9-081">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Nadorff</surname>
            <given-names>Michael R</given-names>
          </name>
          <xref ref-type="aff" rid="af4-nss-9-081">4</xref>
          <xref ref-type="aff" rid="af5-nss-9-081">5</xref>
        </contrib>
      </contrib-group>
      <aff id="af1-nss-9-081"><label>1</label>Sleep &amp; Human Health Institute</aff>
      <aff id="af2-nss-9-081"><label>2</label>Maimonides Sleep Arts &amp; Sciences, Ltd, Albuquerque</aff>
      <aff id="af3-nss-9-081"><label>3</label>Los Alamos Medical Center, Los Alamos, NM</aff>
      <aff id="af4-nss-9-081"><label>4</label>Department of Psychology, Mississippi State University, Mississippi, MS</aff>
      <aff id="af5-nss-9-081"><label>5</label>Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA</aff>
      <author-notes>
        <corresp id="c1-nss-9-081">Correspondence: Barry Krakow, Sleep &amp; Human Health Institute, 6739 Academy Rd NE, Ste 380, Albuquerque, NM 87109, USA, Tel +1 505 998 7204, Fax +1 505 998 7220, Email <email>bkrakow@sleeptreatment.com</email></corresp>
      </author-notes>
      <pub-date pub-type="collection">
        <year>2017</year>
      </pub-date>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>3</month>
        <year>2017</year>
      </pub-date>
      <volume>9</volume>
      <fpage>81</fpage>
      <lpage>95</lpage>
      <permissions>
        <copyright-statement>© 2017 Krakow et al. This work is published and licensed by Dove Medical Press Limited</copyright-statement>
        <copyright-year>2017</copyright-year>
        <license>
          <license-p>The full terms of this license are available at <ext-link ext-link-type="uri" xlink:href="https://www.dovepress.com/terms.php">https://www.dovepress.com/terms.php</ext-link> and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by-nc/3.0/">http://creativecommons.org/licenses/by-nc/3.0/</ext-link>). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.</license-p>
        </license>
      </permissions>
      <abstract>
        <sec>
          <title>Purpose</title>
          <p><citation_analysis attribute="positive">Emerging evidence shows that positive airway pressure (PAP) treatment of obstructive sleep apnea (OSA) and upper airway resistance syndrome (UARS) in chronic insomnia patients (proposed “complex insomnia” disorder) leads to substantial decreases in insomnia severity. Although continuous PAP (CPAP) is the pressure mode most widely researched, intolerance to fixed pressurized air is rarely investigated or described in comorbidity patients. This retrospective study examined dual pressure, autoadjusting PAP modes in chronic, complex insomnia disorder patients.</citation_analysis></p>
        </sec>
        <sec>
          <title>Patients and methods</title>
          <p><citation_analysis attribute="positive">Chronic insomnia disorder patients (mean [SD] insomnia severity index [ISI] =19.11 [3.34]) objectively diagnosed with OSA or UARS and using either autobilevel PAP device or adaptive servoventilation (ASV) device after failing CPAP therapy (frequently due to intolerance to pressurized air, poor outcomes, or emergence of CSA) were divided into PAP users (≥20 h/wk) and partial users (&lt;20 h/wk) for comparison. Subjective and objective baseline and follow-up measures were analyzed.</citation_analysis></p>
        </sec>
        <sec>
          <title>Results</title>
          <p><citation_analysis attribute="positive">Of the 302 complex insomnia patients, PAP users (n=246) averaged 6.10 (1.78) nightly hours and 42.71 (12.48) weekly hours and partial users (n=56) averaged 1.67 (0.76) nightly hours and 11.70 (5.31) weekly hours. For mean (SD) decreases in total ISI scores, a significant (group × time) interaction was observed (</citation_analysis><citation_analysis attribute="positive"><italic>F</italic></citation_analysis><citation_analysis attribute="neither">[1,300]=13.566; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">&lt;0.0001) with PAP users (–7.59 [5.92]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=1.63) showing superior results to partial users (−4.34 [6.13]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="positive">=0.81). Anecdotally, patients reported better tolerability with advanced PAP compared to previous experience with CPAP. Both adaptive servoventilation and autobilevel PAP showed similar ISI score improvement without statistical differences between devices. Total weekly hours of PAP use correlated inversely with change in insomnia symptoms (</citation_analysis><citation_analysis attribute="positive"><italic>r</italic></citation_analysis><citation_analysis attribute="neither">=−0.256, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">&lt;0.01).</citation_analysis></p>
        </sec>
        <sec>
          <title>Conclusion</title>
          <p><citation_analysis attribute="positive">Insomnia severity significantly decreased in patients using autoadjusting PAP devices, but the study design restricts interpretation to an association. Future research must elucidate the interaction between insomnia and OSA/UARS as well as the adverse influence of pressure intolerance on PAP adaptation in complex insomnia patients. Randomized controlled studies must determine whether advanced PAP modes provide benefits over standard CPAP modes in these comorbidity patients.</citation_analysis></p>
        </sec>
      </abstract>
      <abstract abstract-type="graphical">
        <title>Video abstract</title>
        <p><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><media xlink:href="nss-9-081-s.avi" xlink:type="simple" id="d35e169" position="anchor" mimetype="video"/></citation_analysis></p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>insomnia</kwd>
        <kwd>obstructive sleep apnea</kwd>
        <kwd>upper airway resistance syndrome</kwd>
        <kwd>CPAP failure</kwd>
        <kwd>autobilevel</kwd>
        <kwd>adaptive servoventilation</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>Introduction</title>
      <p><citation_analysis attribute="neither">Chronic insomnia is noted to be the “most prevalent sleep disorder worldwide”.</citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-9-081" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="positive"> Extensive research has evaluated the etiology and assessment of insomnia,</citation_analysis><citation_analysis attribute="positive"><xref rid="b2-nss-9-081" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b7-nss-9-081" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither"> economic impact,</citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-9-081" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b5-nss-9-081" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b8-nss-9-081" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-9-081" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> and evidence-based pharmacological and nonpharmacological treatments.</citation_analysis><citation_analysis attribute="positive"><xref rid="b1-nss-9-081" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b5-nss-9-081" ref-type="bibr">5</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b6-nss-9-081" ref-type="bibr">6</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b9-nss-9-081" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b11-nss-9-081" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither"> Yet, according to Edinger et al</citation_analysis><citation_analysis attribute="positive"><xref rid="b12-nss-9-081" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> “[t]he optimal insomnia nosology has yet to be determined.” In a recent prospective, validation study, the constructs of “insomnia due to [various conditions] and </citation_analysis><citation_analysis attribute="positive"><italic>obstructive sleep apnea</italic></citation_analysis><citation_analysis attribute="neither"> were well supported”.</citation_analysis><citation_analysis attribute="positive"><xref rid="b12-nss-9-081" ref-type="bibr">12</xref></citation_analysis><citation_analysis attribute="neither"> Surprisingly, only a small corpus of research has investigated the relationships between obstructive sleep apnea (OSA) or upper airway resistance syndrome (UARS) and insomnia.</citation_analysis><citation_analysis attribute="positive"><xref rid="b13-nss-9-081" ref-type="bibr">13</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b17-nss-9-081" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither"> In the earliest works, Guilleminault et al</citation_analysis><citation_analysis attribute="positive"><xref rid="b18-nss-9-081" ref-type="bibr">18</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b19-nss-9-081" ref-type="bibr">19</xref></citation_analysis><citation_analysis attribute="neither"> showed a link between central sleep apnea and insomnia. More than 20 years later, Lichstein et al</citation_analysis><citation_analysis attribute="positive"><xref rid="b20-nss-9-081" ref-type="bibr">20</xref></citation_analysis><citation_analysis attribute="positive"> demonstrated an OSA rate of 43% in older insomnia patients; and in 2001, we proposed the term “complex insomnia” to categorize the comorbidity between chronic insomnia and OSA or UARS, after the unexpected discovery of a 90% rate of objectively diagnosed sleep breathing disorders in a consecutive series of crime victims seeking treatment for insomnia and nightmares.</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-9-081" ref-type="bibr">21</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">From other clinical perspectives, several research groups have demonstrated that 30–60% of OSA patients present with clinically meaningful comorbid insomnia symptoms.</citation_analysis><citation_analysis attribute="positive"><xref rid="b17-nss-9-081" ref-type="bibr">17</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b22-nss-9-081" ref-type="bibr">22</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b25-nss-9-081" ref-type="bibr">25</xref></citation_analysis><citation_analysis attribute="positive"> In a recent study among a large sample of chronic insomnia disorder patients regularly using yet failing prescription or over-the-counter sleep aids, 91% were objectively diagnosed with OSA or UARS.</citation_analysis><citation_analysis attribute="positive"><xref rid="b26-nss-9-081" ref-type="bibr">26</xref></citation_analysis><citation_analysis attribute="neither"> Nasal cannula pressure transducer technology appears to yield the most accurate rates of complex insomnia in the samples studied.</citation_analysis><citation_analysis attribute="positive"><xref rid="b27-nss-9-081" ref-type="bibr">27</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Much as these findings are thought-provoking; a series of commentaries on causal relationships between insomnia and sleep-disordered breathing have been especially provocative by raising questions about a potential bidirectional relationship between insomnia and sleep breathing disorders.</citation_analysis><citation_analysis attribute="positive"><xref rid="b28-nss-9-081" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b31-nss-9-081" ref-type="bibr">31</xref></citation_analysis><citation_analysis attribute="positive"> And, each of these published viewpoints noted a likely requirement for multimodal, evidence-based treatments to address this unusual comorbidity, that is, treatment of insomnia symptoms may require cognitive behavioral therapy for insomnia (CBT-I) or sedatives as well as positive airway pressure (PAP) therapy.</citation_analysis><citation_analysis attribute="positive"><xref rid="b28-nss-9-081" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b29-nss-9-081" ref-type="bibr">29</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b31-nss-9-081" ref-type="bibr">31</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">Nine studies conducted since 2000 evaluated the effects of sleep-disordered breathing treatments on chronic insomnia (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t1-nss-9-081">Table 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis><citation_analysis attribute="positive"><xref rid="b32-nss-9-081" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b40-nss-9-081" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="positive"> All studies, despite weaknesses of retrospective designs in the majority, systematically demonstrated clear-cut improvements following the use of PAP, upper airway surgery, bariatric surgery, or nasal dilator strips.</citation_analysis><citation_analysis attribute="positive"><xref rid="b32-nss-9-081" ref-type="bibr">32</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b40-nss-9-081" ref-type="bibr">40</xref></citation_analysis><citation_analysis attribute="neither"> One of the 9 studies looked at PAP therapy sequentially applied after CBT-I.</citation_analysis><citation_analysis attribute="positive"><xref rid="b37-nss-9-081" ref-type="bibr">37</xref></citation_analysis><citation_analysis attribute="neither"> In another study, a small sample of insomnia patients (n=56) who previously failed and then ceased the use of standard forms of continuous PAP (CPAP) therapy were subsequently titrated with adaptive servoventilation (ASV), after which 75% of them reinitiated PAP with this advanced technology.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither"> Among the 39 ASV users, large decreases in the insomnia severity index (ISI)</citation_analysis><citation_analysis attribute="positive"><xref rid="b2-nss-9-081" ref-type="bibr">2</xref></citation_analysis><citation_analysis attribute="neither"> were noted (16.8 vs 9.7; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=1.40) after an average of 1.3 years of ASV use.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">A distinctive observation in this ASV study pinpointed the ubiquitous inability of chronic insomnia disorder patients with comorbid OSA/UARS to adapt to standard PAP devices, such as continuous positive airway pressure (CPAP), continuous positive airway pressure with expiratory pressure relief (CFLEX), automatic continuous positive airway pressure (APAP), and Bilevel positive airway pressure (BPAP) due to self-reported discomfort and intolerance triggered by the vaguely defined phenomenon of expiratory pressure intolerance (EPI)</citation_analysis><citation_analysis attribute="positive"><xref rid="b41-nss-9-081" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b42-nss-9-081" ref-type="bibr">42</xref></citation_analysis><citation_analysis attribute="positive"> even among those using PAP devices with basic expiratory pressure relief (EPR) systems.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="positive"> These adverse effects resolved with ASV use,</citation_analysis><citation_analysis attribute="positive"><xref rid="b43-nss-9-081" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither"> and in our clinical experience, many insomnia patients also adapt well to autobilevel PAP (ABPAP) devices.</citation_analysis><citation_analysis attribute="positive"><xref rid="b43-nss-9-081" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b44-nss-9-081" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither"> Anecdotally, manually titrated, autoadjusting algorithms embedded in these devices create a smoother airflow delivery system, which in turn diminishes insomnia patients’ anxious responses to pressurized air.</citation_analysis><citation_analysis attribute="positive"><xref rid="b43-nss-9-081" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b44-nss-9-081" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="positive"> These findings are consistent with prior research showing the inadequacy of exclusive reliance on autotitrating algorithms in these devices,</citation_analysis><citation_analysis attribute="positive"><xref rid="b45-nss-9-081" ref-type="bibr">45</xref></citation_analysis><citation_analysis attribute="neither"> despite their known ambulatory rescue capabilities.</citation_analysis><citation_analysis attribute="positive"><xref rid="b46-nss-9-081" ref-type="bibr">46</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-9-081" ref-type="bibr">47</xref></citation_analysis></p>
      <p><citation_analysis attribute="positive">To examine the effects of manually titrated, dual-pressure, autoadjusting technologies on insomnia outcomes, we conducted a retrospective chart review on a nonrandomized controlled cohort of chronic insomnia patients who presented with moderate-to-severe symptoms and comorbid OSA/UARS. All patients were currently using advanced PAP technology. We hypothesized:
</citation_analysis><citation_analysis attribute="positive"><list list-type="order"><list-item><p><citation_analysis attribute="positive">Regular users of advanced PAP devices would demonstrate greater decreases in insomnia severity compared to a control group of partial users;</citation_analysis></p></list-item><list-item><p><citation_analysis attribute="neither">Increased hours of use of advanced PAP technology would correlate inversely with change in insomnia severity.</citation_analysis></p></list-item></list></citation_analysis></p>
    </sec>
    <sec sec-type="methods|subjects">
      <title>Patients and methods</title>
      <sec sec-type="methods">
        <title>Study criteria and consent</title>
        <p><citation_analysis attribute="positive">Adult patients who met the following criteria were included: 1) ISI ≥15; 2) subjective report of multiple indicators of psychophysiological insomnia, poor sleep hygiene or psychiatric comorbidity as the most likely causes of insomnia; 3) objectively diagnosed OSA (apnea–hypopnea index [AHI] ≥5) or UARS (AHI &lt;5 and respiratory disturbance index ≥15); 4) failed standard forms of PAP therapy (see “Procedure for CPAP failure determination” section for detailed explanation) at Maimonides Sleep Arts &amp; Sciences (MSAS) or at a previous sleep facility; 5) completed one or more in-lab manual titrations with autoadjusting technology; 6) filled a prescription, initiated and maintained the use of ABPAP or ASV, and returned for follow-up; and 7) provided subjective and objective follow-up measures at clinic appointments. As per standard protocol at MSAS, all patients provided verbal and written consents for their medical information to be used anonymously for research and educational purposes in the context of chart and data reviews. This study was approved by Los Alamos Medical Center’s Institutional Review Board.</citation_analysis></p>
      </sec>
      <sec>
        <title>Chart review and extracted sample</title>
        <p><citation_analysis attribute="positive">This retrospective chart review commenced with all patients seen at MSAS between March 2011 and August 2014 (n=1,967). Adult patients were included who presented with intake ISI scores ≥15, diagnosed with OSA or UARS, and underwent a titration polysomnography (PSG). Of the 590 eligible patients, 438 patients filled prescriptions for ABPAP or ASV, of whom 302 patients provided follow-up outcome measures (ISI and Epworth Sleepiness Scale [ESS]) and objective data downloads (ODD) on average 6.9 months from the initiation of therapy (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f1-nss-9-081">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec>
        <title>Procedure for CPAP failure determination</title>
        <p><citation_analysis attribute="neither">In our clinical experience in working with predominantly psychiatric patients with sleep disorders, we observed frequent problems with EPI triggered by fixed pressurized airflow devices,</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b43-nss-9-081" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b44-nss-9-081" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither"> and this phenomenon often heralds “claustrophobic tendencies” in relationship to or irrespective of mask issues.</citation_analysis><citation_analysis attribute="positive"><xref rid="b48-nss-9-081" ref-type="bibr">48</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b50-nss-9-081" ref-type="bibr">50</xref></citation_analysis><citation_analysis attribute="neither"> Since 2005, our policies and procedures focused on preventing or eliminating EPI and related claustrophobic tendencies in vulnerable patients with co-occurring insomnia and psychiatric conditions (Supplementary materials).</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b44-nss-9-081" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b51-nss-9-081" ref-type="bibr">51</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b55-nss-9-081" ref-type="bibr">55</xref></citation_analysis><citation_analysis attribute="neither"> As noted in </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f2-nss-9-081">Figure 2</xref></citation_analysis><citation_analysis attribute="neither">, </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f3-nss-9-081">3</xref></citation_analysis><citation_analysis attribute="positive"> main pathways ultimately led to CPAP failure in this study cohort, and subjective and objective EPI were the most common problems, necessitating a switch to advanced PAP devices. Overall, taking into account patients’ efforts to attempt multiple modes of PAP, the average patient experienced multiple (~5 per patient) reasons for failure.</citation_analysis></p>
        <p><citation_analysis attribute="negative">Of the 89 patients prescribed PAP devices to use at home, failure was mainly due to poor outcomes (persistently elevated ISI, fatigue, or daytime symptoms despite PAP therapy use), subjective EPI, and aborted use (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f2-nss-9-081">Figure 2A</xref></citation_analysis><citation_analysis attribute="negative">). For 205 patients during their prestudy PAP desensitization, subjective expiratory intolerance was the main reason for traditional PAP mode failures (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f2-nss-9-081">Figure 2B</xref></citation_analysis><citation_analysis attribute="neither">). For 268 patients undergoing a sleep technologist conducted titration, PAP failure was largely due to objectively observed EPI, emergent central-like pause(s), complex sleep apnea (CompSA), and residual sleep breathing events persisting despite pressure increases (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f2-nss-9-081">Figure 2C</xref></citation_analysis><citation_analysis attribute="neither">). A total of 1,625 specific indications of failure manifested with various PAP modes for these 302 patients, which eventually led to insurance coverage for the use of autoadjusting PAP technology.</citation_analysis></p>
      </sec>
      <sec>
        <title>PSG and titration practice model for autoadjusting technology</title>
        <p><citation_analysis attribute="neither">PSG was conducted and scored with American Academy of Sleep Medicine (AASM) guidelines to diagnose OSA/UARS.</citation_analysis><citation_analysis attribute="positive"><xref rid="b56-nss-9-081" ref-type="bibr">56</xref></citation_analysis><citation_analysis attribute="neither"> For titrations, our policies and procedures align with AASM guidelines</citation_analysis><citation_analysis attribute="positive"><xref rid="b41-nss-9-081" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither"> and other research</citation_analysis><citation_analysis attribute="positive"><xref rid="b57-nss-9-081" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="neither"> to normalize the airflow curve by eliminating all breathing events including respiratory effort-related arousals (RERAs).</citation_analysis><citation_analysis attribute="positive"><xref rid="b41-nss-9-081" ref-type="bibr">41</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b57-nss-9-081" ref-type="bibr">57</xref></citation_analysis><citation_analysis attribute="positive"> We also follow 2006 AASM practice parameters for BPAP indications “[…]where high pressure is needed and the patient experiences difficulty exhaling against a fixed pressure[….]” This adverse EPI effect (described earlier for CPAP failure) occurs while increasing the pressure to resolve RERAs, especially for patients on fixed CPAP. Subjective or objective EPI manifests in patients with anxiety symptoms (an omnipresent insomnia finding). When manually titrating advanced technology in the sleep laboratory, a fine-tuning process permits minute increases in inspiratory pressures to treat RERAs while simultaneously providing concomitant pressure relief through fastidious titration of expiratory pressures. Thus, the synergistic goals of normalized airflow and patient comfort are achieved.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-9-081" ref-type="bibr">47</xref></citation_analysis></p>
        <p><citation_analysis attribute="neither">A sequential changing of pressure delivery modes follows an algorithm that begins with CPAP, which then moves to either CPAP or APAP with an EPR setting or to BPAP, followed by ABPAP and finally ASV when CompSA or in some cases subthreshold CompSA develops. To eliminate RERAs without aggravating EPI, pressures are titrated by 0.2–0.4 cm/H</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="neither">O increments.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-9-081" ref-type="bibr">47</xref></citation_analysis></p>
      </sec>
      <sec>
        <title>Advanced PAP technology prescription practices</title>
        <p><citation_analysis attribute="neither">Using the above algorithm in the manual titration of autoadjusting dual-pressure devices has resulted in the vast majority of complex insomnia patients ultimately receiving a prescription for either an ABPAP device or an ASV device at our center, which specializes in the treatment of complex patients suffering psychiatric comorbidities. Thus, a minority of patients used standard CPAP devices at home. Some used APAP or BPAP devices for varying periods of time before returning to the sleep center with the complaint of poor to mediocre results, at which point a repeat titration was conducted, and ABPAP or ASV was prescribed as qualified by insurance criteria.</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-9-081" ref-type="bibr">47</xref></citation_analysis></p>
      </sec>
      <sec>
        <title>Subjective and objective determinations of hours of PAP use</title>
        <p><citation_analysis attribute="negative">Hours of PAP use and percentage of nights used (nights with PAP use divided by total number of nights) were determined by ODD. Rarely (&lt;10% of sample), ODDs were not available due to computer or software malfunction. In these instances, subjective report for hours of PAP use was determined by patient report on bed time, wake time, time of mask removal, estimated nightly PAP use, and corroboration with bed partner. ODD was available for 275 patients (ASV =177; ABPAP =98), and personal estimates of nightly use were obtained in 27 patients (ASV =22; ABPAP =5).</citation_analysis></p>
        <p><citation_analysis attribute="neither">Nonrandom assignment divided patients into the following 2 groups: PAP users (n=246; ≥20 h/wk, averaging 6.10 [1.78] h/night and 42.71 [12.48] h/wk) and partial users (n=56; &lt;20 h/wk, averaging 1.67 [0.76] h/night and 11.70 [5.31] h/wk). The cutoff value of 20 h/wk was calculated based on CMS compliance standards of 70% of nights with ≥4 h per night use (ie, 4.9 nights ≥4 h =19.6 h/wk).</citation_analysis></p>
      </sec>
      <sec>
        <title>Additional metrics</title>
        <p><citation_analysis attribute="positive">Intake and follow-up scores for ISI questions # 1–3 were analyzed individually to examine changes in the type of insomnia: sleep onset insomnia (SOI), sleep maintenance insomnia (SMI), and early morning awakening (EMA). To further identify insomnia severity, subjective sleep indices (time in bed, total sleep time, sleep onset latency, and wake after sleep onset) were reported at intake; sleep efficiency was calculated from these responses. As an additional measure of change in insomnia, frequency of sleep aid use was gathered at intake and clarified at follow-up. Psychiatric history (including trauma history and claustrophobia) was obtained at intake to identify comorbid disorders. To evaluate the presence of comorbid sleep disorders, patients treating periodic limb movement disorder or restless leg syndrome were identified at the time of most recent follow-up.</citation_analysis></p>
      </sec>
      <sec sec-type="methods">
        <title>Data analyses</title>
        <p><citation_analysis attribute="positive">Descriptive statistics provided baseline characteristics, including sociodemographics and standard self-report sleep metrics and hours of objective use of PAP therapy. Analysis of variance (ANOVA) compared use means among groups. PAP user and partial user groups, as well as ASV and ABPAP groups, were compared for changes in insomnia severity with repeated measures ANOVA, including within- and between-subjects analyses while controlling for subjective psychiatric comorbidities. Pearson product-moment correlations were conducted on hours of use by change in insomnia symptom severity. Cohen’s </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither"> measured within-subjects effect sizes, and Hedge’s </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither"> measured between-subjects effect sizes due to unequal sample sizes. Statistical significance was 0.05. All continuous variables were expressed as mean (SD).</citation_analysis></p>
      </sec>
    </sec>
    <sec sec-type="results">
      <title>Results</title>
      <sec sec-type="intro">
        <title>Baseline characteristics</title>
        <p><citation_analysis attribute="positive">Our study sample was predominantly overweight (body mass index =31.59 [8.00]), Caucasian (61.9%) or Hispanic (28.1%), married or living with partner (67.2%), males (55.6%) with a bachelor’s degree or higher (48.0%), and age 53.44 (14.21) years. OSA was diagnosed in 274 and UARS in 28 patients. ESS total score was 10.89 (6.02), just above the most conservative cutoff for clinically meaningful daytime sleepiness (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t2-nss-9-081">Table 2</xref></citation_analysis><citation_analysis attribute="neither">). For 246 PAP users, 156 used ASV and 90 used ABPAP, and for 56 partial users, 43 used ASV and 13 used ABPAP (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f1-nss-9-081">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="positive">Subjective intake data were consistent with chronic insomnia in the moderate-to-severe range (ISI score =19.11 [3.34]) with an insomnia chronicity of 10.28 (7.33) years. </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f3-nss-9-081">Figure 3</xref></citation_analysis><citation_analysis attribute="positive"> identifies indicators of psychophysiological conditioning and poor sleep hygiene, which patients directly attributed to their insomnia, such as learning to be a poor sleeper, losing sleep over losing sleep, and time monitoring behavior. Patients endorsed an average of 9.48 (3.68) of a possible 18 indicators for maladaptive sleep behaviors. Medical co-morbidities were reported in 96.7% of all patients (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t2-nss-9-081">Table 2</xref></citation_analysis><citation_analysis attribute="positive">, see Supplementary Results for details of system categories). Three-quarters (75.2%) of all patients reported at least one psychiatric condition or disorder (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t2-nss-9-081">Table 2</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec sec-type="methods">
        <title>Hours of use by objective data or subjective report by PAP mode</title>
        <p><citation_analysis attribute="neither">Nightly and weekly hours of use were nearly identical for ASV users (6.10 [1.84], 42.68 [12.90]) and ABPAP users (6.11 [1.68], 42.78 [11.79]). Nightly hours for ASV and ABPAP partial users (1.57 [0.79] vs 2.01 [0.55]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.067, </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=0.58) and weekly hours (10.98 [5.51] vs 14.07 [3.86]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.065, </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="positive">=0.59) were not significantly different, albeit the effect sizes indicated that ABPAP use was moderately greater than ASV use. There was a significant difference in the percentage of nights used between PAP users and partial users (93.7 [10.2] vs 59.6 [24.4]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001, </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=2.44); no difference was found between modes among PAP users (93.5 [10.2] vs 94.0 [10.2]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.7, </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=0.05) or partial users (57.9 [26.3] vs 65.4 [16.7]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.3, </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=0.27) for ASV vs ABPAP respectively (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f1-nss-9-081">Figure 1</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
      </sec>
      <sec>
        <title>Changes in insomnia severity</title>
        <p><citation_analysis attribute="positive">For decreases in total ISI scores, a significant (group × time) interaction was observed (</citation_analysis><citation_analysis attribute="positive"><italic>F</italic></citation_analysis><citation_analysis attribute="neither">[1,288]=13.895; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">&lt;0.0001) with PAP users (−7.59 [5.92]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=1.63) showing superior results compared to partial users (−4.34 [6.13]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.81). Clinical severity decreased markedly in the PAP user group to below the currently applied clinical cutoff of 15, equivalent to less than a moderate level of insomnia (11.43 [5.73]), whereas partial users remained above the moderate level of severity (15.18 [6.60]) (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f4-nss-9-081">Figure 4A</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="neither">Within PAP users, ISI scores significantly decreased for both the ASV (n=156; −7.32 [5.98]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=1.55; </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f4-nss-9-081">Figure 4B</xref></citation_analysis><citation_analysis attribute="neither">), and ABPAP groups (n=90; −8.02 [5.83]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=1.78; </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f4-nss-9-081">Figure 4C</xref></citation_analysis><citation_analysis attribute="positive">) without significant differences between PAP modes (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.59).</citation_analysis></p>
        <p><citation_analysis attribute="neither">In partial users, ISI scores significantly decreased for the ASV group (n=43; −5.00 [6.19]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.97; </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f4-nss-9-081">Figure 4B</xref></citation_analysis><citation_analysis attribute="positive">), but ISI decrease among ABPAP users was not significant (n=13; −2.15 [5.63]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.33; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.39; </citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f4-nss-9-081">Figure 4C</xref></citation_analysis><citation_analysis attribute="neither">), albeit without differences between groups (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.24; </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=0.46).</citation_analysis></p>
        <p><citation_analysis attribute="positive">To provide a more clinically relevant view of the changes in insomnia severity, we measured the following 2 ISI clinical cutoffs: subclinical insomnia (&lt;11) and nonclinical insomnia (&lt;8). There was a significant difference in PAP users vs partial users attaining subclinical ISI scores (112 [45.5%] vs 15 [26.8%], </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="positive">=0.01). Nonclinical ISI scores were attained in 59 (24.0%) PAP users and 9(16.1%) partial users, with no significant difference between the groups, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.20.</citation_analysis></p>
        <p><citation_analysis attribute="positive">Examining individual insomnia subtype scores (SOI, SMI, and EMA) at intake revealed no significant differences between PAP users and partial users. Follow-up scores for each of the 3 insomnia subtypes showed significant improvement in the PAP users (n=243) with large effect sizes, whereas partial users’ (n=56) improvements were non-significant with small-to-medium effect sizes (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f5-nss-9-081">Figure 5A</xref></citation_analysis><citation_analysis attribute="neither">). Mean improvements were as follows in the PAP user group: SOI (-0.76 [1.14]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.70), SMI (−0.86 [1.19]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.87), and EMA (−0.74 [1.43]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.65).</citation_analysis></p>
        <p><citation_analysis attribute="neither">Within ASV subjects, users’ (n=154) ISI subtype scores significantly decreased as follows: SOI (−0.64 [1.14]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.58), SMI (−0.83 [1.20]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.86), and EMA (−0.67 [1.33]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.58) (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f5-nss-9-081">Figure 5B</xref></citation_analysis><citation_analysis attribute="neither">). And, within ABPAP subjects, users’ (n=89) insomnia subtype scores significantly decreased as follows: SOI (−0.96 [1.13]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.94), SMI (−0.90 [1.17]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.90), and EMA (−0.88 [1.58]; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.74) (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="fig" rid="f5-nss-9-081">Figure 5C</xref></citation_analysis><citation_analysis attribute="neither">).</citation_analysis></p>
        <p><citation_analysis attribute="positive">Of the 302 total patients, 135 reported taking prescription or over-the-counter medications for insomnia at intake (108 PAP users [ASV 74 and ABPAP 34] and 28 partial users [ASV 20 and ABPAP 8]) (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="supplementary-material" rid="SD1-nss-9-081">Table S1</xref></citation_analysis><citation_analysis attribute="positive"> for the list of medications). At follow-up, 80 of the 135 sleep aid users reported no change in insomnia medication, whereas 40 reported a decrease in medication, including 33 PAP users (ASV 23 and ABPAP 10) and 7 partial users (ASV 3 and ABPAP 4). An additional 3 patients reported an increase in medication (ASV users 3).</citation_analysis></p>
        <p><citation_analysis attribute="positive">Numerous significant changes also occurred with day-time sleepiness outcomes (ESS), but effects were small (Supplementary materials). There was a significantly greater proportion of PAP users treating leg jerks compared to partial users. However, when comparing change in ISI score for PAP users vs partial users treating leg jerks, no significant difference was found (Supplementary materials). Controlling for psychiatric history also did not affect results.</citation_analysis></p>
      </sec>
      <sec>
        <title>Correlations between hours of use and change in insomnia severity</title>
        <p><citation_analysis attribute="neither">When analyzing all 302 patients, total weekly hours of PAP use correlated inversely with change in insomnia symptoms (</citation_analysis><citation_analysis attribute="positive"><italic>r</italic></citation_analysis><citation_analysis attribute="neither">=−0.256, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">&lt;0.01). Looking at each mode individually, insomnia symptoms decreased with total weekly hours of PAP use for all ASV patients (n=199, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001, </citation_analysis><citation_analysis attribute="positive"><italic>r</italic></citation_analysis><citation_analysis attribute="neither">=−0.235) and for all ABPAP patients (n=103, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.002, </citation_analysis><citation_analysis attribute="positive"><italic>r</italic></citation_analysis><citation_analysis attribute="positive">=−0.299), suggesting potential efficacy in both groups. The difference between the 2 correlations was not significant (</citation_analysis><citation_analysis attribute="positive"><italic>z</italic></citation_analysis><citation_analysis attribute="neither">=0.56, </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.58).</citation_analysis></p>
      </sec>
    </sec>
    <sec sec-type="discussion">
      <title>Discussion</title>
      <p><citation_analysis attribute="neither">In a medium-size clinical sample of OSA/UARS patients diagnosed with comorbid, moderate-to-severe insomnia symptoms (the proposed complex insomnia designation),</citation_analysis><citation_analysis attribute="positive"><xref rid="b21-nss-9-081" ref-type="bibr">21</xref></citation_analysis><citation_analysis attribute="positive"> large improvements manifested in association with the use of manually titrated, autoadjusting PAP technology. Correlations between hours of use with either ASV or ABPAP and improvements in insomnia were highly significant. Taken together, the findings appear to support the emerging theory on OSA/UARS as a causative factor in insomnia pathophysiology, albeit in the absence of a randomized controlled prospective trial, the results of this case series of clinical patients can only be described as an association between sleep-disordered breathing and insomnia symptoms. However, from an anecdotal perspective, it seemed clear that these advanced devices proved especially well-suited for relieving the problem of EPI among vulnerable insomnia patients suffering from generalized distress or specific anxiety about using PAP therapy.</citation_analysis></p>
      <p><citation_analysis attribute="neither">Future studies must use more rigorous protocols to evaluate the relationships between these 2 most common sleep disorders. Although a small number of studies have already been conducted (</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t1-nss-9-081">Table 1</xref></citation_analysis><citation_analysis attribute="positive">), new protocols are needed with various evidence-based forms of therapy for OSA/UARS, including different PAP therapy modes, oral appliances, upper airway surgery, and even weight loss treatments. Based on this study and that of past research, newer studies must quantify more precisely the extent to which the treatment of sleep breathing problems improves insomnia symptoms as well as the extent of residual insomnia symptoms. Programs with combination therapies including PAP and CBT-I or PAP and sedatives are likely to provide the most clinical relevance and generalizability, given the high proportion of insomnia disorder patients who would benefit optimally from both treatments instead of just one. Urgent research is warranted to examine PAP vs CBT-I, PAP vs PAP/CBT-I, and finally PAP/CBT-I vs CBT-I, because of the growing demand for nonpharmacological treatment of insomnia</citation_analysis><citation_analysis attribute="positive"><xref rid="b11-nss-9-081" ref-type="bibr">11</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b28-nss-9-081" ref-type="bibr">28</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b58-nss-9-081" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither"> as well as the rising need to increase access for evidence-based insomnia interventions through on-line therapies.</citation_analysis><citation_analysis attribute="positive"><xref rid="b58-nss-9-081" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b59-nss-9-081" ref-type="bibr">59</xref></citation_analysis><citation_analysis attribute="neither"> Results should attempt to rapidly clarify how best to implement these treatment regimens in clinical and non-clinical settings.</citation_analysis></p>
      <p><citation_analysis attribute="neither">To assist in the development of this new therapeutic framework, we initiated a randomized single-blind, controlled study on the benefits of ASV vs CPAP therapy in chronic insomnia disorder patients (clinical trials # NCT02365064). Also, other clinical and research groups have begun development to treat complex insomnia patients with multimodal therapies,</citation_analysis><citation_analysis attribute="positive"><xref rid="b58-nss-9-081" ref-type="bibr">58</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b60-nss-9-081" ref-type="bibr">60</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b62-nss-9-081" ref-type="bibr">62</xref></citation_analysis><citation_analysis attribute="neither"> and early results suggest the importance of these approaches.</citation_analysis></p>
      <p><citation_analysis attribute="positive">The study has several limitations due to the nonrandomized, retrospective case series design with a medium-sized sample. Selection bias may have occurred as not all insomnia patients presenting to our center underwent PSG testing or filled their PAP prescriptions. Thus, by focusing only on users of PAP devices, our results provide no information on cost-effectiveness. The cohort reported a wide range of psychiatric comorbidity that may limit generalizability of our findings. Information regarding other factors such as medication changes, other insomnia treatments, and education on sleep hygiene was unavailable for this review. Regardless of the potential therapeutic impact, speculatively PAP may have acted as a relaxation placebo for some patients. Also, this cohort may have been more motivated to pursue treatment, and the results may not translate to insomniacs who did not move forward with diagnostic or treatment steps. Our sleep center focuses on an experiential model of patient education via greater use of hands-on coaching and titrations</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-9-081" ref-type="bibr">47</xref></citation_analysis><citation_analysis attribute="positive"> as well as encouraging struggling patients to reach out rapidly to problem solve. These 2 patient-centric features of our sleep medical center may lead to greater interactions between the patients and our sleep staff and, therefore, might limit the generalizability of our findings for centers that might spend less time with their patients. In addition, ineffective treatment or nontreatment of comorbid sleep disorders could have had an effect on PAP use and, in some cases, insomnia severity. Our data represent an association between advanced PAP technology and observed decreases in insomnia; a prospective, randomized controlled protocol with monitoring of longitudinal progress is needed to confirm or reject these findings in a sample of chronic insomnia patients. In particular, it will prove highly relevant to determine whether or not more advanced PAP technology devices are more suitable for complex insomnia patients.</citation_analysis></p>
    </sec>
    <sec>
      <title>Conclusion</title>
      <p><citation_analysis attribute="positive">Improvements in insomnia severity were greater in regular users of autoadjusting PAP devices compared to a nonrandom control group of partial users, and the former group demonstrated average decreases in insomnia below the clinical ISI cutoff for moderate insomnia. Increased hours of autoadjusting PAP use correlated inversely with change in insomnia severity. Autoadjusting PAP devices seemed especially salient for complex insomnia patients, who were prone to anxious tendencies that may have increased vulnerability to EPI and claustrophobic feelings. Speculatively, advanced PAP technology may provide an adaptation advantage for those who might otherwise struggle with traditional PAP therapy devices.</citation_analysis><citation_analysis attribute="positive"><xref rid="b39-nss-9-081" ref-type="bibr">39</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b43-nss-9-081" ref-type="bibr">43</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b44-nss-9-081" ref-type="bibr">44</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b47-nss-9-081" ref-type="bibr">47</xref></citation_analysis></p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary materials</title>
      <sec sec-type="methods">
        <title>Methods</title>
        <p><citation_analysis attribute="positive">Although research and conventional wisdom often allude to a very narrow window (eg, 3–4 d) in which patients may accept or reject positive airway pressure (PAP) therapy,</citation_analysis><citation_analysis attribute="positive"><xref rid="b63-nss-9-081" ref-type="bibr">1</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b65-nss-9-081" ref-type="bibr">3</xref></citation_analysis><citation_analysis attribute="neither"> there does not seem to be a formal policy or protocol on how to act on this information to improve patient compliance. Patients are commonly sent home on continuous PAP (CPAP) with the notion that they will learn to get used to it, notwithstanding their progress by day 4.</citation_analysis></p>
        <p><citation_analysis attribute="neither">In our sleep laboratory, we proactively attempt to trouble-shoot issues that may interfere early in the patient’s adaptation experience.</citation_analysis><citation_analysis attribute="positive"><xref rid="b66-nss-9-081" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b70-nss-9-081" ref-type="bibr">8</xref></citation_analysis><citation_analysis attribute="neither"> Our desensitization protocol on the night of the titration seeks extensive patient feedback regarding comfort with both pressurized air and the mask. Instead of presuming that the patient will tolerate pressurized airflow over time, we make the assumption that more discomfort indicates a lesser likelihood for adaptation. Thus, when a patient reports discomfort with mask or pressurized air, we seek to remedy the discomfort during the desensitization or the actual titration. Although, in some cases, the discomfort may be minor and easily fixed by changing a mask size or style, we often encounter more serious complaints with pressurized air that are best defined as claustrophobic tendencies or frank claustrophobic responses.</citation_analysis><citation_analysis attribute="positive"><xref rid="b66-nss-9-081" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">–</citation_analysis><citation_analysis attribute="positive"><xref rid="b70-nss-9-081" ref-type="bibr">8</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Our objective is to increase physiological and psychological comforts during the desensitization and titration instead of waiting for discomfort to abort the patient’s effort when using PAP at home. In practical terms, every patient will try CPAP, but in vulnerable insomnia and psychiatric patients, there is usually an immediate, negative response to this mode due to difficulties breathing out against fixed pressurized air. Most patients rapidly report the elimination of this discomfort, accompanied by a new sense of comfort, after switching to a dual-pressure device. Later, while asleep during the titration, we seek to eliminate all respiratory effort-related arousals (RERAs) without provoking further episodes of subjective or objective expiratory pressure intolerance (EPI), and we have found manually titrating patients on autoadjusting dual-pressure devices (adaptive servoventilation [ASV] and autobilevel PAP [ABPAP]) to be well-suited to achieve these results.</citation_analysis><citation_analysis attribute="positive"><xref rid="b66-nss-9-081" ref-type="bibr">4</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b69-nss-9-081" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b70-nss-9-081" ref-type="bibr">8</xref></citation_analysis></p>
        <p><citation_analysis attribute="positive">Last, in applying our protocol to eliminate RERAs as well as EPI, we have also noticed a set of objective markers that tend to correlate with a normalized airflow signal – normal on both inspiration and expiration. Specifically, a normalized airflow signal appears linked to fewer arousals, awakenings, and sleep stage shifts,</citation_analysis><citation_analysis attribute="positive"><xref rid="b69-nss-9-081" ref-type="bibr">7</xref></citation_analysis><citation_analysis attribute="neither">,</citation_analysis><citation_analysis attribute="positive"><xref rid="b71-nss-9-081" ref-type="bibr">9</xref></citation_analysis><citation_analysis attribute="neither"> as well as a greater degree of sleep efficiency, rapid eye movement (REM) sleep rebound,</citation_analysis><citation_analysis attribute="positive"><xref rid="b72-nss-9-081" ref-type="bibr">10</xref></citation_analysis><citation_analysis attribute="neither"> and possibly REM sleep consolidation (uninterrupted periods of REM sleep) as described by Riemann et al.</citation_analysis><citation_analysis attribute="positive"><xref rid="b73-nss-9-081" ref-type="bibr">11</xref></citation_analysis></p>
      </sec>
      <sec sec-type="results">
        <title>Results</title>
        <p><citation_analysis attribute="positive">Medical comorbidities are reported in </citation_analysis><citation_analysis attribute="positive"><xref ref-type="table" rid="t2-nss-9-081">Table 2</xref></citation_analysis><citation_analysis attribute="positive">. Of the 302 patients, 292 patients reported at least one medical comorbidity with an average of &gt;5 comorbidities per patient. Comorbidities were classified into categories and were defined as: arthritis/pain – arthritis (96), chronic fatigue syndrome (23), chronic pain (85), fibromyalgia (23); cardiac – heart disease (9), myocardial infarction (8), heart failure (2), premature ventricular contractions (8), atrial fibrillation (10), bradycardia (5), tachycardia (13), heart surgery (16), and other heart conditions (17); drug/alcohol abuse – drug addiction (13) and alcoholism (14); endocrine – diabetes (44), menopausal symptoms (51), obesity (111), thyroid problems (59); hypertension (133); kidney – bladder problems (55) and kidney problems (9); neurologic – epilepsy/seizure (10), head injury with concussion (50), head injury without concussion (29), and stroke (6); pulmonary – allergies (177), asthma (54), deviated septum (61), emphysema (3), nasal trauma (16), sinus problems (113), current smoker (18), former smoker (68), and tonsillectomy (69); and reflux (115).</citation_analysis></p>
        <p><citation_analysis attribute="neither">Epworth Sleepiness Scale (ESS) scores for the entire sample decreased by 2.47 (5.14) from 10.89 (6.02) to 8.42 (5.44) (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="positive">=0.43). The PAP user group (n=246) showed a significant decrease in ESS scores (mean [SD] =2.60 [5.35]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.46). Among ASV users (n=156), ESS scores significantly decreased (2.93 [5.34]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.50), and among ABPAP users, ESS scores significantly decreased (2.03 [5.35]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.01; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="positive">=0.38) without significant differences between PAP pressure modes (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.20; </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=0.17).</citation_analysis></p>
        <p><citation_analysis attribute="neither">ESS scores did not significantly decrease for the 56 partial users (mean [SD] change =1.91 [4.12]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.10; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.31), the 43 ASV partial users (2.05 [4.30]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.13; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.33), or the 13 ABPAP partial users (1.46 [3.57]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.55; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="positive">=0.23) without significant difference between PAP pressure modes (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.66; </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="positive">=0.14). There was no significant difference between changes in ESS scores among PAP modes (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.21; </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither">=0.15), although the changes within each mode were significant: ASV (2.74 [5.13]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.46) and ABPAP (1.96 [5.15]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.01; </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="neither">=0.36).</citation_analysis></p>
        <p><citation_analysis attribute="positive">There was a significant difference in the proportion of patients treating leg jerks between users and partial users (84/246 [34.1%] vs 10/56 [17.9%]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="positive">=0.017). Similar findings existed within ASV user and partial user groups (58/156 [37.2%] vs 9/43 [20.9%]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="positive">=0.047); among ABPAP patients, there were too few partial user subjects to allow statistical analysis. Among ASV and ABPAP users, there were no significant differences in the proportions of patients treating leg jerks (67/199 [33.7%] vs 27/103 [26.2%]; </citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="positive">=0.19). Change in insomnia severity index score from intake to follow-up for users (19.29 [3.33]–12.06 [5.98]) and partial users (19.40 [3.27]–12.80 [5.31]) treating leg jerks compared to users (18.88 [3.18]–11.10 [5.59]) and partial users (19.54 [3.93]–15.70 [6.79]) not treating leg jerks was not significant (</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.14).</citation_analysis></p>
        <supplementary-material content-type="local-data" id="SD1-nss-9-081">
          <table-wrap id="ts1-nss-9-081" position="float">
            <label>Table S1</label>
            <caption>
              <p><citation_analysis attribute="neither">Categorized medications used for insomnia at intake</citation_analysis></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th valign="top" align="left" rowspan="1" colspan="1">Benzodiazepines</th>
                  <th valign="top" align="left" rowspan="1" colspan="1">Nonbenzodiazepines</th>
                  <th valign="top" align="left" rowspan="1" colspan="1">Mood stabilizers/antidepressants</th>
                  <th valign="top" align="left" rowspan="1" colspan="1">Over the counter</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1">Lorazepam, 5.6%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Zolpidem, 33.1%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Trazodone, 18.5%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Antihistamines, 42.7%</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1">Temazepam, 5.6%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Eszopiclone, 8.9%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Amitriptyline, 4.0%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Melatonin, 41.3%</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1">Alprazolam, 4.0%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1">Mirtazapine, 2.4%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1">Herbal, 16.0%</td>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1">Clonazepam, 4.0%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1">Quetiapine, 1.6%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1">Diazepam, 2.4%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1">Carbamazepine, 0.8%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1">Triazolam, 0.8%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1">Clomipramine, 0.8%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1">Doxepin, 0.8%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
                <tr>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                  <td valign="top" align="left" rowspan="1" colspan="1">Nortriptyline, 0.8%</td>
                  <td valign="top" align="left" rowspan="1" colspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="tfn15-nss-9-081">
                <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="positive"> Percentage of total prescription medications and percentage of total over the counter medications are reported. Prescription medication used for sleep that did not fit into the above categories included hydroxyzine (1.6%), opiates (1.6%), hydroxybutanoic acid (0.8%), pregabalin (0.8%), and ramelteon (0.8%). One patient reported the use of recreational marijuana for insomnia.</citation_analysis></p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </supplementary-material>
        <ref-list>
          <title>References</title>
          <ref id="b63-nss-9-081">
            <label>1</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Budhiraja</surname>
                  <given-names>R</given-names>
                </name>
                <name>
                  <surname>Parthasarathy</surname>
                  <given-names>S</given-names>
                </name>
                <name>
                  <surname>Drake</surname>
                  <given-names>CL</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Early CPAP use identifies subsequent adherence to CPAP therapy</article-title>
              <source>Sleep</source>
              <year>2007</year>
              <volume>30</volume>
              <issue>3</issue>
              <fpage>320</fpage>
              <lpage>324</lpage>
              <pub-id pub-id-type="pmid">17425228</pub-id>
            </element-citation>
          </ref>
          <ref id="b64-nss-9-081">
            <label>2</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Weaver</surname>
                  <given-names>TE</given-names>
                </name>
                <name>
                  <surname>Kribbs</surname>
                  <given-names>NB</given-names>
                </name>
                <name>
                  <surname>Pack</surname>
                  <given-names>AI</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Night-to-night variability in CPAP use over the first three months of treatment</article-title>
              <source>Sleep</source>
              <year>1997</year>
              <volume>20</volume>
              <issue>4</issue>
              <fpage>278</fpage>
              <lpage>283</lpage>
              <pub-id pub-id-type="pmid">9231953</pub-id>
            </element-citation>
          </ref>
          <ref id="b65-nss-9-081">
            <label>3</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Weaver</surname>
                  <given-names>TE</given-names>
                </name>
                <name>
                  <surname>Grunstein</surname>
                  <given-names>RR</given-names>
                </name>
              </person-group>
              <article-title>Adherence to continuous positive airway pressure therapy: the challenge to effective treatment</article-title>
              <source>Proc Am Thorac Soc</source>
              <year>2008</year>
              <volume>5</volume>
              <issue>2</issue>
              <fpage>173</fpage>
              <lpage>178</lpage>
              <pub-id pub-id-type="pmid">18250209</pub-id>
            </element-citation>
          </ref>
          <ref id="b66-nss-9-081">
            <label>4</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Krakow</surname>
                  <given-names>B</given-names>
                </name>
                <name>
                  <surname>Ulibarri</surname>
                  <given-names>VA</given-names>
                </name>
                <name>
                  <surname>Foley-Shea</surname>
                  <given-names>MR</given-names>
                </name>
                <name>
                  <surname>Tidler</surname>
                  <given-names>A</given-names>
                </name>
                <name>
                  <surname>McIver</surname>
                  <given-names>ND</given-names>
                </name>
              </person-group>
              <article-title>Adherence and subthreshold adherence in sleep apnea subjects receiving positive airway pressure therapy: a retrospective study evaluating differences in adherence versus use</article-title>
              <source>Respir Care</source>
              <year>2016</year>
              <volume>61</volume>
              <issue>8</issue>
              <fpage>1023</fpage>
              <lpage>1032</lpage>
              <pub-id pub-id-type="pmid">27118876</pub-id>
            </element-citation>
          </ref>
          <ref id="b67-nss-9-081">
            <label>5</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Krakow</surname>
                  <given-names>B</given-names>
                </name>
                <name>
                  <surname>Melendrez</surname>
                  <given-names>D</given-names>
                </name>
                <name>
                  <surname>Haynes</surname>
                  <given-names>P</given-names>
                </name>
              </person-group>
              <article-title>Integrating psychosocial and biomedical CPAP adherence models. A commentary on: “improving CPAP use by patients with the sleep apnea/hypopnea syndrome (SAHS)” (HM Engleman &amp; MR Wild)</article-title>
              <source>Sleep Med Rev</source>
              <year>2003</year>
              <volume>7</volume>
              <issue>5</issue>
              <fpage>441</fpage>
              <lpage>444</lpage>
              <pub-id pub-id-type="pmid">14573379</pub-id>
            </element-citation>
          </ref>
          <ref id="b68-nss-9-081">
            <label>6</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Krakow</surname>
                  <given-names>B</given-names>
                </name>
                <name>
                  <surname>Ulibarri</surname>
                  <given-names>V</given-names>
                </name>
                <name>
                  <surname>Melendrez</surname>
                  <given-names>D</given-names>
                </name>
                <name>
                  <surname>Kikta</surname>
                  <given-names>S</given-names>
                </name>
                <name>
                  <surname>Togami</surname>
                  <given-names>L</given-names>
                </name>
                <name>
                  <surname>Haynes</surname>
                  <given-names>P</given-names>
                </name>
              </person-group>
              <article-title>A daytime, abbreviated cardio-respiratory sleep study (CPT 95807-52) to acclimate insomnia patients with sleep disordered breathing to positive airway pressure (PAP-NAP)</article-title>
              <source>J Clin Sleep Med</source>
              <year>2008</year>
              <volume>4</volume>
              <issue>3</issue>
              <fpage>212</fpage>
              <lpage>222</lpage>
              <pub-id pub-id-type="pmid">18595433</pub-id>
            </element-citation>
          </ref>
          <ref id="b69-nss-9-081">
            <label>7</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Krakow</surname>
                  <given-names>B</given-names>
                </name>
                <name>
                  <surname>Ulibarri</surname>
                  <given-names>VA</given-names>
                </name>
                <name>
                  <surname>Sanchez</surname>
                  <given-names>JN</given-names>
                </name>
                <name>
                  <surname>Kikta</surname>
                  <given-names>S</given-names>
                </name>
                <name>
                  <surname>McIver</surname>
                  <given-names>N</given-names>
                </name>
                <name>
                  <surname>Melendrez</surname>
                  <given-names>D</given-names>
                </name>
              </person-group>
              <article-title>Driving on “auto”: hands-on is more effective than hands-free</article-title>
              <source>J Clin Sleep Med</source>
              <year>2012</year>
              <volume>8</volume>
              <issue>3</issue>
              <fpage>343</fpage>
              <lpage>344</lpage>
              <pub-id pub-id-type="pmid">22701395</pub-id>
            </element-citation>
          </ref>
          <ref id="b70-nss-9-081">
            <label>8</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Krakow</surname>
                  <given-names>B</given-names>
                </name>
                <name>
                  <surname>Ulibarri</surname>
                  <given-names>VA</given-names>
                </name>
                <name>
                  <surname>Romero</surname>
                  <given-names>EA</given-names>
                </name>
                <name>
                  <surname>Thomas</surname>
                  <given-names>RJ</given-names>
                </name>
                <name>
                  <surname>McIver</surname>
                  <given-names>ND</given-names>
                </name>
              </person-group>
              <article-title>Adaptive servo-ventilation therapy in a case series of patients with co-morbid insomnia and sleep apnea</article-title>
              <source>J Sleep Disord Treat Care</source>
              <year>2013</year>
              <volume>2</volume>
              <fpage>1</fpage>
              <lpage>10</lpage>
            </element-citation>
          </ref>
          <ref id="b71-nss-9-081">
            <label>9</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Laffan</surname>
                  <given-names>A</given-names>
                </name>
                <name>
                  <surname>Caffo</surname>
                  <given-names>B</given-names>
                </name>
                <name>
                  <surname>Swihart</surname>
                  <given-names>BJ</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>Utility of sleep stage transitions in assessing sleep continuity</article-title>
              <source>Sleep</source>
              <year>2010</year>
              <volume>33</volume>
              <issue>12</issue>
              <fpage>1681</fpage>
              <lpage>1686</lpage>
              <pub-id pub-id-type="pmid">21120130</pub-id>
            </element-citation>
          </ref>
          <ref id="b72-nss-9-081">
            <label>10</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Koo</surname>
                  <given-names>BB</given-names>
                </name>
                <name>
                  <surname>Wiggins</surname>
                  <given-names>R</given-names>
                </name>
                <name>
                  <surname>Molina</surname>
                  <given-names>C</given-names>
                </name>
              </person-group>
              <article-title>REM rebound and CPAP compliance</article-title>
              <source>Sleep Med</source>
              <year>2012</year>
              <volume>13</volume>
              <issue>7</issue>
              <fpage>864</fpage>
              <lpage>868</lpage>
              <pub-id pub-id-type="pmid">22705243</pub-id>
            </element-citation>
          </ref>
          <ref id="b73-nss-9-081">
            <label>11</label>
            <element-citation publication-type="journal">
              <person-group person-group-type="author">
                <name>
                  <surname>Riemann</surname>
                  <given-names>D</given-names>
                </name>
                <name>
                  <surname>Spiegelhalder</surname>
                  <given-names>K</given-names>
                </name>
                <name>
                  <surname>Nissen</surname>
                  <given-names>C</given-names>
                </name>
                <etal/>
              </person-group>
              <article-title>REM sleep instability – a new pathway for insomnia?</article-title>
              <source>Pharmacopsychiatry</source>
              <year>2012</year>
              <volume>45</volume>
              <issue>5</issue>
              <fpage>167</fpage>
              <lpage>176</lpage>
              <pub-id pub-id-type="pmid">22290199</pub-id>
            </element-citation>
          </ref>
        </ref-list>
      </sec>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgments</title>
      <p><citation_analysis attribute="neither">We are grateful to the Los Alamos Medical Center and the Los Alamos Medical Center Sleep Laboratory for administrative and clinical assistance in the completion of this study. This study did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors.</citation_analysis></p>
    </ack>
    <fn-group>
      <fn fn-type="COI-statement">
        <p><citation_analysis attribute="positive">
          </citation_analysis><citation_analysis attribute="positive"><bold>Disclosure</bold></citation_analysis><citation_analysis attribute="positive">
        </citation_analysis></p>
        <p><citation_analysis attribute="neither">Dr Krakow’s financial disclosures are as follows. He has 6 main activities related to his work in sleep medicine. For websites, he owns and operates the following 6 sites that provide education and offer products and services for sleep disorder patients: </citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.nightmaretreatment.com">www.nightmaretreatment.com</ext-link></citation_analysis><citation_analysis attribute="neither">, </citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.ptsdsleepclinic.com">www.ptsdsleepclinic.com</ext-link></citation_analysis><citation_analysis attribute="neither">, </citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.sleeptreatment.com">www.sleeptreatment.com</ext-link></citation_analysis><citation_analysis attribute="neither">, </citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.sleepdynamictherapy.com">www.sleepdynamictherapy.com</ext-link></citation_analysis><citation_analysis attribute="neither">, </citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.soundsleep-soundmind.com">www.soundsleep-soundmind.com</ext-link></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.nocturiacures.com">www.nocturiacures.com</ext-link></citation_analysis><citation_analysis attribute="neither">. Regarding other professional services, he is the medical director of a National DME company Classic SleepCare</citation_analysis><citation_analysis attribute="positive"><sup>®</sup></citation_analysis><citation_analysis attribute="neither"> for which his sole functions are consultation and quality assurance. He has neither patient encounters nor does he benefit from the sale of any DME equipment. For intellectual property, he markets and sells the following 3 books for sleep disorder patients: </citation_analysis><citation_analysis attribute="positive"><italic>Insomnia Cures</italic></citation_analysis><citation_analysis attribute="neither">, </citation_analysis><citation_analysis attribute="positive"><italic>Turning Nightmares into Dreams</italic></citation_analysis><citation_analysis attribute="neither">, and </citation_analysis><citation_analysis attribute="positive"><italic>Sound Sleep, Sound Mind</italic></citation_analysis><citation_analysis attribute="neither">. For clinical services, he owns and operates the following commercial sleep center: Maimonides Sleep Arts &amp; Sciences, Ltd. For educational and consulting services, he conducts CME/CEU educational programs for medical and mental health providers to learn about sleep disorders. Sometimes these programs involve the attendee paying a fee directly to our center. Other times, he conducts the workshops at other locations, which may be paid for by vendors such as Respironics and ResMed or other institutions such as the AMEDDC&amp;S, VAMC, and regional sleep center conferences. He is also a president of a nonprofit sleep research center, the Sleep &amp; Human Health Institute (</citation_analysis><citation_analysis attribute="positive"><ext-link ext-link-type="uri" xlink:href="http://www.shhi.org">www.shhi.org</ext-link></citation_analysis><citation_analysis attribute="neither">) that occasionally provides consultation services or receives grants for pilot studies, the most recent of which was ResMed ~$400,000 January 2015 (funding for randomized control trial of PAP treatment in insomnia patients). The authors report no other conflicts of interest in this work.</citation_analysis></p>
      </fn>
    </fn-group>
    <ref-list>
      <title>References</title>
      <ref id="b1-nss-9-081">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Unbehaun</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Spiegelhalder</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hirscher</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Riemann</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Management of insomnia: update and new approaches</article-title>
          <source>Nat Sci Sleep</source>
          <year>2010</year>
          <volume>2</volume>
          <fpage>127</fpage>
          <lpage>138</lpage>
          <pub-id pub-id-type="pmid">23616705</pub-id>
        </element-citation>
      </ref>
      <ref id="b2-nss-9-081">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bastien</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Vallieres</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Morin</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Validation of the insomnia severity index as an outcome measure for insomnia research</article-title>
          <source>Sleep Med</source>
          <year>2001</year>
          <volume>2</volume>
          <issue>4</issue>
          <fpage>297</fpage>
          <lpage>307</lpage>
          <pub-id pub-id-type="pmid">11438246</pub-id>
        </element-citation>
      </ref>
      <ref id="b3-nss-9-081">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edinger</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Bonnet</surname>
              <given-names>MH</given-names>
            </name>
            <name>
              <surname>Bootzin</surname>
              <given-names>RR</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Derivation of research diagnostic criteria for insomnia: report of an American Academy of Sleep Medicine Work Group</article-title>
          <source>Sleep</source>
          <year>2004</year>
          <volume>27</volume>
          <issue>8</issue>
          <fpage>1567</fpage>
          <lpage>1596</lpage>
          <pub-id pub-id-type="pmid">15683149</pub-id>
        </element-citation>
      </ref>
      <ref id="b4-nss-9-081">
        <label>4</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Richardson</surname>
              <given-names>GS</given-names>
            </name>
          </person-group>
          <article-title>Human physiological models of insomnia</article-title>
          <source>Sleep Med</source>
          <year>2007</year>
          <volume>8</volume>
          <issue>suppl 4</issue>
          <fpage>S9</fpage>
          <lpage>S14</lpage>
          <pub-id pub-id-type="pmid">18346677</pub-id>
        </element-citation>
      </ref>
      <ref id="b5-nss-9-081">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Roth</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Introduction – advances in our understanding of insomnia and its management</article-title>
          <source>Sleep Med</source>
          <year>2007</year>
          <volume>8</volume>
          <issue>suppl 3</issue>
          <fpage>25</fpage>
          <lpage>26</lpage>
          <pub-id pub-id-type="pmid">18032105</pub-id>
        </element-citation>
      </ref>
      <ref id="b6-nss-9-081">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schutte-Rodin</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Broch</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Buysse</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Dorsey</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sateia</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Clinical guideline for the evaluation and management of chronic insomnia in adults</article-title>
          <source>J Clin Sleep Med</source>
          <year>2008</year>
          <volume>4</volume>
          <issue>5</issue>
          <fpage>487</fpage>
          <lpage>504</lpage>
          <pub-id pub-id-type="pmid">18853708</pub-id>
        </element-citation>
      </ref>
      <ref id="b7-nss-9-081">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Riemann</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Spiegelhalder</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Feige</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>The hyperarousal model of insomnia: a review of the concept and its evidence</article-title>
          <source>Sleep Med Rev</source>
          <year>2010</year>
          <volume>14</volume>
          <issue>1</issue>
          <fpage>19</fpage>
          <lpage>31</lpage>
          <pub-id pub-id-type="pmid">19481481</pub-id>
        </element-citation>
      </ref>
      <ref id="b8-nss-9-081">
        <label>8</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Botteman</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Health economics of insomnia therapy: implications for policy</article-title>
          <source>Sleep Med</source>
          <year>2009</year>
          <volume>10</volume>
          <issue>suppl 1</issue>
          <fpage>S22</fpage>
          <lpage>S25</lpage>
          <pub-id pub-id-type="pmid">19647482</pub-id>
        </element-citation>
      </ref>
      <ref id="b9-nss-9-081">
        <label>9</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hussain</surname>
              <given-names>MT</given-names>
            </name>
            <name>
              <surname>Shea</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>Wake up to insomnia: future approaches to the management of insomnia</article-title>
          <source>Nat Sci Sleep</source>
          <year>2011</year>
          <volume>3</volume>
          <fpage>33</fpage>
          <lpage>35</lpage>
          <pub-id pub-id-type="pmid">23616716</pub-id>
        </element-citation>
      </ref>
      <ref id="b10-nss-9-081">
        <label>10</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pigeon</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Bishop</surname>
              <given-names>TM</given-names>
            </name>
            <name>
              <surname>Marcus</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Advances in the management of insomnia</article-title>
          <source>F1000Prime Rep</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>48</fpage>
          <pub-id pub-id-type="pmid">24991425</pub-id>
        </element-citation>
      </ref>
      <ref id="b11-nss-9-081">
        <label>11</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harsora</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Kessmann</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Nonpharmacologic management of chronic insomnia</article-title>
          <source>Am Fam Physician</source>
          <year>2009</year>
          <volume>79</volume>
          <issue>2</issue>
          <fpage>125</fpage>
          <lpage>130</lpage>
          <pub-id pub-id-type="pmid">19178064</pub-id>
        </element-citation>
      </ref>
      <ref id="b12-nss-9-081">
        <label>12</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edinger</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Wyatt</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Stepanski</surname>
              <given-names>EJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Testing the reliability and validity of DSM-IV-TR and ICSD-2 insomnia diagnoses. Results of a multitrait-multimethod analysis</article-title>
          <source>Arch Gen Psychiatry</source>
          <year>2011</year>
          <volume>68</volume>
          <issue>10</issue>
          <fpage>992</fpage>
          <lpage>1002</lpage>
          <pub-id pub-id-type="pmid">21646568</pub-id>
        </element-citation>
      </ref>
      <ref id="b13-nss-9-081">
        <label>13</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beneto</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Gomez-Siurana</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Rubio-Sanchez</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Comorbidity between sleep apnea and insomnia</article-title>
          <source>Sleep Med Rev</source>
          <year>2009</year>
          <volume>13</volume>
          <issue>4</issue>
          <fpage>287</fpage>
          <lpage>293</lpage>
          <pub-id pub-id-type="pmid">19246219</pub-id>
        </element-citation>
      </ref>
      <ref id="b14-nss-9-081">
        <label>14</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lavie</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Insomnia and sleep-disordered breathing</article-title>
          <source>Sleep Med</source>
          <year>2007</year>
          <volume>8</volume>
          <issue>suppl 4</issue>
          <fpage>S21</fpage>
          <lpage>S25</lpage>
          <pub-id pub-id-type="pmid">18346673</pub-id>
        </element-citation>
      </ref>
      <ref id="b15-nss-9-081">
        <label>15</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luyster</surname>
              <given-names>FS</given-names>
            </name>
            <name>
              <surname>Buysse</surname>
              <given-names>DJ</given-names>
            </name>
            <name>
              <surname>Strollo</surname>
              <given-names>PJ</given-names>
              <suffix>Jr</suffix>
            </name>
          </person-group>
          <article-title>Comorbid insomnia and obstructive sleep apnea: challenges for clinical practice and research</article-title>
          <source>J Clin Sleep Med</source>
          <year>2010</year>
          <volume>6</volume>
          <issue>2</issue>
          <fpage>196</fpage>
          <lpage>204</lpage>
          <pub-id pub-id-type="pmid">20411700</pub-id>
        </element-citation>
      </ref>
      <ref id="b16-nss-9-081">
        <label>16</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wickwire</surname>
              <given-names>EM</given-names>
            </name>
            <name>
              <surname>Collop</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Insomnia and sleep-related breathing disorders</article-title>
          <source>Chest</source>
          <year>2010</year>
          <volume>137</volume>
          <issue>6</issue>
          <fpage>1449</fpage>
          <lpage>1463</lpage>
          <pub-id pub-id-type="pmid">20525657</pub-id>
        </element-citation>
      </ref>
      <ref id="b17-nss-9-081">
        <label>17</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>E</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Prevalence of insomnia symptoms in patients with sleep-disordered breathing</article-title>
          <source>Chest</source>
          <year>2001</year>
          <volume>120</volume>
          <issue>6</issue>
          <fpage>1923</fpage>
          <lpage>1929</lpage>
          <pub-id pub-id-type="pmid">11742923</pub-id>
        </element-citation>
      </ref>
      <ref id="b18-nss-9-081">
        <label>18</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guilleminault</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Eldridge</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Dement</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Insomnia with sleep apnea: a new syndrome</article-title>
          <source>Science</source>
          <year>1973</year>
          <volume>181</volume>
          <issue>4102</issue>
          <fpage>856</fpage>
          <lpage>858</lpage>
          <pub-id pub-id-type="pmid">4353301</pub-id>
        </element-citation>
      </ref>
      <ref id="b19-nss-9-081">
        <label>19</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guilleminault</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Eldridge</surname>
              <given-names>FL</given-names>
            </name>
            <name>
              <surname>Phillips</surname>
              <given-names>JR</given-names>
            </name>
            <name>
              <surname>Dement</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Two occult causes of insomnia and their therapeutic problems</article-title>
          <source>Arch Gen Psychiatry</source>
          <year>1976</year>
          <volume>33</volume>
          <issue>10</issue>
          <fpage>1241</fpage>
          <lpage>1245</lpage>
          <pub-id pub-id-type="pmid">971033</pub-id>
        </element-citation>
      </ref>
      <ref id="b20-nss-9-081">
        <label>20</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lichstein</surname>
              <given-names>KL</given-names>
            </name>
            <name>
              <surname>Riedel</surname>
              <given-names>BW</given-names>
            </name>
            <name>
              <surname>Lester</surname>
              <given-names>KW</given-names>
            </name>
            <name>
              <surname>Aguillard</surname>
              <given-names>RN</given-names>
            </name>
          </person-group>
          <article-title>Occult sleep apnea in a recruited sample of older adults with insomnia</article-title>
          <source>J Consult Clin Psychol</source>
          <year>1999</year>
          <volume>67</volume>
          <issue>3</issue>
          <fpage>405</fpage>
          <lpage>410</lpage>
          <pub-id pub-id-type="pmid">10369061</pub-id>
        </element-citation>
      </ref>
      <ref id="b21-nss-9-081">
        <label>21</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Pedersen</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Complex insomnia: insomnia and sleep-disordered breathing in a consecutive series of crime victims with nightmares and PTSD</article-title>
          <source>Biol Psychiatry</source>
          <year>2001</year>
          <volume>49</volume>
          <issue>11</issue>
          <fpage>948</fpage>
          <lpage>953</lpage>
          <pub-id pub-id-type="pmid">11377413</pub-id>
        </element-citation>
      </ref>
      <ref id="b22-nss-9-081">
        <label>22</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guilleminault</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Palombini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Poyares</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chowdhuri</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Chronic insomnia, postmenopausal women, and sleep disordered breathing: part 1. Frequency of sleep disordered breathing in a cohort</article-title>
          <source>J Psychosom Res</source>
          <year>2002</year>
          <volume>53</volume>
          <issue>1</issue>
          <fpage>611</fpage>
          <lpage>615</lpage>
          <pub-id pub-id-type="pmid">12127179</pub-id>
        </element-citation>
      </ref>
      <ref id="b23-nss-9-081">
        <label>23</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krell</surname>
              <given-names>SB</given-names>
            </name>
            <name>
              <surname>Kapur</surname>
              <given-names>VK</given-names>
            </name>
          </person-group>
          <article-title>Insomnia complaints in patients evaluated for obstructive sleep apnea</article-title>
          <source>Sleep Breath</source>
          <year>2005</year>
          <volume>9</volume>
          <issue>3</issue>
          <fpage>104</fpage>
          <lpage>110</lpage>
          <pub-id pub-id-type="pmid">16091954</pub-id>
        </element-citation>
      </ref>
      <ref id="b24-nss-9-081">
        <label>24</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hagen</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Patel</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McCall</surname>
              <given-names>WV</given-names>
            </name>
          </person-group>
          <article-title>Prevalence of insomnia symptoms in sleep laboratory patients with and without sleep apnea</article-title>
          <source>Psychiatry Res</source>
          <year>2009</year>
          <volume>170</volume>
          <issue>2–3</issue>
          <fpage>276</fpage>
          <lpage>277</lpage>
          <pub-id pub-id-type="pmid">19896722</pub-id>
        </element-citation>
      </ref>
      <ref id="b25-nss-9-081">
        <label>25</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Smith</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Sullivan</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Hopkins</surname>
              <given-names>W</given-names>
            </name>
            <name>
              <surname>Douglas</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Frequency of insomnia report in patients with obstructive sleep apnoea hypopnea syndrome (OSAHS)</article-title>
          <source>Sleep Med</source>
          <year>2004</year>
          <volume>5</volume>
          <issue>5</issue>
          <fpage>449</fpage>
          <lpage>456</lpage>
          <pub-id pub-id-type="pmid">15341889</pub-id>
        </element-citation>
      </ref>
      <ref id="b26-nss-9-081">
        <label>26</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Pharmacotherapeutic failure in a large cohort of patients with insomnia presenting to a sleep medicine center and laboratory: subjective pretest predictions and objective diagnoses</article-title>
          <source>Mayo Clin Proc</source>
          <year>2014</year>
          <volume>89</volume>
          <issue>12</issue>
          <fpage>1608</fpage>
          <lpage>1620</lpage>
          <pub-id pub-id-type="pmid">25236429</pub-id>
        </element-citation>
      </ref>
      <ref id="b27-nss-9-081">
        <label>27</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>BJ</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Moore</surname>
              <given-names>BA</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Posttraumatic stress disorder and sleep-disordered breathing: a review of comorbidity research</article-title>
          <source>Sleep Med Rev</source>
          <year>2015</year>
          <volume>24</volume>
          <fpage>37</fpage>
          <lpage>45</lpage>
          <pub-id pub-id-type="pmid">25644985</pub-id>
        </element-citation>
      </ref>
      <ref id="b28-nss-9-081">
        <label>28</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pigeon</surname>
              <given-names>WR</given-names>
            </name>
            <name>
              <surname>Sateia</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Is insomnia a breathing disorder?</article-title>
          <source>Sleep</source>
          <year>2012</year>
          <volume>35</volume>
          <fpage>1589</fpage>
          <lpage>1590</lpage>
          <pub-id pub-id-type="pmid">23204600</pub-id>
        </element-citation>
      </ref>
      <ref id="b29-nss-9-081">
        <label>29</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lanier</surname>
              <given-names>WL</given-names>
            </name>
            <name>
              <surname>Ramar</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Sleep medication failure and newly diagnosed obstructive sleep apnea: the role of brain function modulation by muscle afferent activity</article-title>
          <source>Mayo Clin Proc</source>
          <year>2014</year>
          <volume>89</volume>
          <issue>12</issue>
          <fpage>1591</fpage>
          <lpage>1595</lpage>
          <pub-id pub-id-type="pmid">25467642</pub-id>
        </element-citation>
      </ref>
      <ref id="b30-nss-9-081">
        <label>30</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collop</surname>
              <given-names>NA</given-names>
            </name>
          </person-group>
          <article-title>Can’t sleep? You may have sleep apnea!</article-title>
          <source>Chest</source>
          <year>2001</year>
          <volume>120</volume>
          <issue>6</issue>
          <fpage>1768</fpage>
          <lpage>1769</lpage>
          <pub-id pub-id-type="pmid">11742898</pub-id>
        </element-citation>
      </ref>
      <ref id="b31-nss-9-081">
        <label>31</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Collop</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>I don’t sleep because I can’t breathe</article-title>
          <source>Sleep Med</source>
          <year>2013</year>
          <volume>14</volume>
          <issue>9</issue>
          <fpage>807</fpage>
          <pub-id pub-id-type="pmid">23746824</pub-id>
        </element-citation>
      </ref>
      <ref id="b32-nss-9-081">
        <label>32</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bjornsdottir</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Janson</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Sigurdsson</surname>
              <given-names>JF</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Symptoms of insomnia among patients with obstructive sleep apnea before and after two years of positive airway pressure treatment</article-title>
          <source>Sleep</source>
          <year>2013</year>
          <volume>36</volume>
          <issue>12</issue>
          <fpage>1901</fpage>
          <lpage>1909</lpage>
          <pub-id pub-id-type="pmid">24293765</pub-id>
        </element-citation>
      </ref>
      <ref id="b33-nss-9-081">
        <label>33</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Glidewell</surname>
              <given-names>RN</given-names>
            </name>
            <name>
              <surname>Renn</surname>
              <given-names>BN</given-names>
            </name>
            <name>
              <surname>Roby</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Orr</surname>
              <given-names>WC</given-names>
            </name>
          </person-group>
          <article-title>Predictors and patterns of insomnia symptoms in OSA before and after PAP therapy</article-title>
          <source>Sleep Med</source>
          <year>2014</year>
          <volume>15</volume>
          <issue>8</issue>
          <fpage>899</fpage>
          <lpage>905</lpage>
          <pub-id pub-id-type="pmid">25011662</pub-id>
        </element-citation>
      </ref>
      <ref id="b34-nss-9-081">
        <label>34</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guilleminault</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Palombini</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Poyares</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Chowdhuri</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Chronic insomnia, premenopausal women and sleep disordered breathing: part 2. Comparison of nondrug treatment trials in normal breathing and UARS post menopausal women complaining of chronic insomnia</article-title>
          <source>J Psychosom Res</source>
          <year>2002</year>
          <volume>53</volume>
          <issue>1</issue>
          <fpage>617</fpage>
          <lpage>623</lpage>
          <pub-id pub-id-type="pmid">12127180</pub-id>
        </element-citation>
      </ref>
      <ref id="b35-nss-9-081">
        <label>35</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guilleminault</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Davis</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Huynh</surname>
              <given-names>NT</given-names>
            </name>
          </person-group>
          <article-title>Prospective randomized study of patients with insomnia and mild sleep disordered breathing</article-title>
          <source>Sleep</source>
          <year>2008</year>
          <volume>31</volume>
          <issue>11</issue>
          <fpage>1527</fpage>
          <lpage>1533</lpage>
          <pub-id pub-id-type="pmid">19014072</pub-id>
        </element-citation>
      </ref>
      <ref id="b36-nss-9-081">
        <label>36</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Lowry</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Germain</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>A retrospective study on improvements in nightmares and post-traumatic stress disorder following treatment for co-morbid sleep-disordered breathing</article-title>
          <source>J Psychosom Res</source>
          <year>2000</year>
          <volume>49</volume>
          <issue>5</issue>
          <fpage>291</fpage>
          <lpage>298</lpage>
          <pub-id pub-id-type="pmid">11164053</pub-id>
        </element-citation>
      </ref>
      <ref id="b37-nss-9-081">
        <label>37</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Lee</surname>
              <given-names>SA</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Clark</surname>
              <given-names>JO</given-names>
            </name>
            <name>
              <surname>Sklar</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Refractory insomnia and sleep-disordered breathing: a pilot study</article-title>
          <source>Sleep Breath</source>
          <year>2004</year>
          <volume>8</volume>
          <issue>1</issue>
          <fpage>15</fpage>
          <lpage>29</lpage>
          <pub-id pub-id-type="pmid">15026935</pub-id>
        </element-citation>
      </ref>
      <ref id="b38-nss-9-081">
        <label>38</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Sisley</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Nasal dilator strip therapy for chronic sleep-maintenance insomnia and symptoms of sleep-disordered breathing: a randomized controlled trial</article-title>
          <source>Sleep Breath</source>
          <year>2006</year>
          <volume>10</volume>
          <issue>1</issue>
          <fpage>16</fpage>
          <lpage>28</lpage>
          <pub-id pub-id-type="pmid">16496118</pub-id>
        </element-citation>
      </ref>
      <ref id="b39-nss-9-081">
        <label>39</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Romero</surname>
              <given-names>EA</given-names>
            </name>
            <name>
              <surname>Thomas</surname>
              <given-names>RJ</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Adaptive servo-ventilation therapy in a case series of patients with co-morbid insomnia and sleep apnea</article-title>
          <source>J Sleep Disord Treat Care</source>
          <year>2013</year>
          <volume>2</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
        </element-citation>
      </ref>
      <ref id="b40-nss-9-081">
        <label>40</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nguyen</surname>
              <given-names>XL</given-names>
            </name>
            <name>
              <surname>Chaskalovic</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Rakotonanahary</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Fleury</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Insomnia symptoms and CPAP compliance in OSAS patients: a descriptive study using data mining methods</article-title>
          <source>Sleep Med</source>
          <year>2010</year>
          <volume>11</volume>
          <issue>8</issue>
          <fpage>777</fpage>
          <lpage>784</lpage>
          <pub-id pub-id-type="pmid">20599419</pub-id>
        </element-citation>
      </ref>
      <ref id="b41-nss-9-081">
        <label>41</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kushida</surname>
              <given-names>CA</given-names>
            </name>
            <name>
              <surname>Chediak</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Berry</surname>
              <given-names>RB</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Clinical guidelines for the manual titration of positive airway pressure in patients with obstructive sleep apnea</article-title>
          <source>J Clin Sleep Med</source>
          <year>2008</year>
          <volume>4</volume>
          <issue>2</issue>
          <fpage>157</fpage>
          <lpage>171</lpage>
          <pub-id pub-id-type="pmid">18468315</pub-id>
        </element-citation>
      </ref>
      <ref id="b42-nss-9-081">
        <label>42</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Resta</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Guido</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Picca</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Scarpelli</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Foschino</surname>
              <given-names>MP</given-names>
            </name>
          </person-group>
          <article-title>The role of the expiratory phase in obstructive sleep apnoea</article-title>
          <source>Respir Med</source>
          <year>1999</year>
          <volume>93</volume>
          <issue>3</issue>
          <fpage>190</fpage>
          <lpage>195</lpage>
          <pub-id pub-id-type="pmid">10464877</pub-id>
        </element-citation>
      </ref>
      <ref id="b43-nss-9-081">
        <label>43</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Foley-Shea</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Tidler</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Adherence and subthreshold adherence in sleep apnea subjects receiving positive airway pressure therapy: a retrospective study evaluating differences in adherence versus use</article-title>
          <source>Respir Care</source>
          <year>2016</year>
          <volume>61</volume>
          <issue>8</issue>
          <fpage>1023</fpage>
          <lpage>1032</lpage>
          <pub-id pub-id-type="pmid">27118876</pub-id>
        </element-citation>
      </ref>
      <ref id="b44-nss-9-081">
        <label>44</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>Sanchez</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Kikta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Driving on “auto”: hands-on is more effective than hands-free</article-title>
          <source>J Clin Sleep Med</source>
          <year>2012</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>343</fpage>
          <lpage>344</lpage>
          <pub-id pub-id-type="pmid">22701395</pub-id>
        </element-citation>
      </ref>
      <ref id="b45-nss-9-081">
        <label>45</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marrone</surname>
              <given-names>O</given-names>
            </name>
            <name>
              <surname>Insalaco</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Salvaggio</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bonsignore</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Role of different nocturnal monitorings in the evaluation of CPAP titration by autoCPAP devices</article-title>
          <source>Respir Med</source>
          <year>2005</year>
          <volume>99</volume>
          <issue>3</issue>
          <fpage>313</fpage>
          <lpage>320</lpage>
          <pub-id pub-id-type="pmid">15733507</pub-id>
        </element-citation>
      </ref>
      <ref id="b46-nss-9-081">
        <label>46</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gentina</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Fortin</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Douay</surname>
              <given-names>B</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Auto bi-level with pressure relief during exhalation as a rescue therapy for optimally treated obstructive sleep apnoea patients with poor compliance to continuous positive airways pressure therapy--a pilot study</article-title>
          <source>Sleep Breath</source>
          <year>2011</year>
          <volume>15</volume>
          <issue>1</issue>
          <fpage>21</fpage>
          <lpage>27</lpage>
          <pub-id pub-id-type="pmid">20204535</pub-id>
        </element-citation>
      </ref>
      <ref id="b47-nss-9-081">
        <label>47</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>ND</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Reversal of CPAP failure with the REPAP retitration protocol</article-title>
          <source>Respir Care</source>
          <year>2017</year>
        </element-citation>
      </ref>
      <ref id="b48-nss-9-081">
        <label>48</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Casas</surname>
              <given-names>I</given-names>
            </name>
            <name>
              <surname>de la Calzada</surname>
              <given-names>MD</given-names>
            </name>
            <name>
              <surname>Guitart</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Roca</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Diagnosis and treatment of the phobia due to treatment with air using nasal continuous pressure</article-title>
          <source>Rev Neurol</source>
          <year>2000</year>
          <volume>30</volume>
          <issue>6</issue>
          <fpage>593</fpage>
          <lpage>596</lpage>
          <pub-id pub-id-type="pmid">10863736</pub-id>
        </element-citation>
      </ref>
      <ref id="b49-nss-9-081">
        <label>49</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chasens</surname>
              <given-names>ER</given-names>
            </name>
            <name>
              <surname>Pack</surname>
              <given-names>AI</given-names>
            </name>
            <name>
              <surname>Maislin</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Dinges</surname>
              <given-names>DF</given-names>
            </name>
            <name>
              <surname>Weaver</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
          <article-title>Claustrophobia and adherence to CPAP treatment</article-title>
          <source>West J Nurs Res</source>
          <year>2005</year>
          <volume>27</volume>
          <issue>3</issue>
          <fpage>307</fpage>
          <lpage>321</lpage>
          <pub-id pub-id-type="pmid">15781905</pub-id>
        </element-citation>
      </ref>
      <ref id="b50-nss-9-081">
        <label>50</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edmonds</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Yang</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>King</surname>
              <given-names>TS</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>DA</given-names>
            </name>
            <name>
              <surname>Rizzo</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Sawyer</surname>
              <given-names>AM</given-names>
            </name>
          </person-group>
          <article-title>Claustrophobic tendencies and continuous positive airway pressure therapy non-adherence in adults with obstructive sleep apnea</article-title>
          <source>Heart Lung</source>
          <year>2015</year>
          <volume>44</volume>
          <issue>2</issue>
          <fpage>100</fpage>
          <lpage>106</lpage>
          <pub-id pub-id-type="pmid">25744632</pub-id>
        </element-citation>
      </ref>
      <ref id="b51-nss-9-081">
        <label>51</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Warner</surname>
              <given-names>TD</given-names>
            </name>
            <name>
              <surname>Dorin</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Harper</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Hollifield</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>To breathe, perchance to sleep: sleep-disordered breathing and chronic insomnia among trauma survivors</article-title>
          <source>Sleep Breath</source>
          <year>2002</year>
          <volume>6</volume>
          <issue>4</issue>
          <fpage>189</fpage>
          <lpage>202</lpage>
          <pub-id pub-id-type="pmid">12524572</pub-id>
        </element-citation>
      </ref>
      <ref id="b52-nss-9-081">
        <label>52</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Haynes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Integrating psychosocial and biomedical CPAP adherence models. A commentary on: “improving CPAP use by patients with the sleep apnea/hypopnea syndrome (SAHS)” (HM Engleman &amp; MR Wild)</article-title>
          <source>Sleep Med Rev</source>
          <year>2003</year>
          <volume>7</volume>
          <issue>5</issue>
          <fpage>441</fpage>
          <lpage>444</lpage>
          <pub-id pub-id-type="pmid">14573379</pub-id>
        </element-citation>
      </ref>
      <ref id="b53-nss-9-081">
        <label>53</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <source>Sound Sleep, Sound Mind: 7 Keys to Sleeping Through the Night</source>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>John Wiley &amp; Sons</publisher-name>
          <year>2007</year>
        </element-citation>
      </ref>
      <ref id="b54-nss-9-081">
        <label>54</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>V</given-names>
            </name>
            <name>
              <surname>Melendrez</surname>
              <given-names>D</given-names>
            </name>
            <name>
              <surname>Kikta</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Togami</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Haynes</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>A daytime, abbreviated cardio-respiratory sleep study (CPT 95807-52) to acclimate insomnia patients with sleep disordered breathing to positive airway pressure (PAP-NAP)</article-title>
          <source>J Clin Sleep Med</source>
          <year>2008</year>
          <volume>4</volume>
          <issue>3</issue>
          <fpage>212</fpage>
          <lpage>222</lpage>
          <pub-id pub-id-type="pmid">18595433</pub-id>
        </element-citation>
      </ref>
      <ref id="b55-nss-9-081">
        <label>55</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Krakow</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Krakow</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Ulibarri</surname>
              <given-names>VA</given-names>
            </name>
            <name>
              <surname>McIver</surname>
              <given-names>ND</given-names>
            </name>
          </person-group>
          <article-title>Frequency and accuracy of “RERA” and “RDI” terms in the Journal of Clinical Sleep Medicine from 2006 through 2012</article-title>
          <source>J Clin Sleep Med</source>
          <year>2014</year>
          <volume>10</volume>
          <issue>2</issue>
          <fpage>121</fpage>
          <lpage>124</lpage>
          <pub-id pub-id-type="pmid">24532993</pub-id>
        </element-citation>
      </ref>
      <ref id="b56-nss-9-081">
        <label>56</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Berry</surname>
              <given-names>RB</given-names>
            </name>
            <name>
              <surname>Budhiraja</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Gottlieb</surname>
              <given-names>DJ</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Rules for scoring respiratory events in sleep: update of the 2007 AASM manual for the scoring of sleep and associated events. deliberations of the sleep apnea definitions Task Force of the American Academy of Sleep Medicine</article-title>
          <source>J Clin Sleep Med</source>
          <year>2012</year>
          <volume>8</volume>
          <issue>5</issue>
          <fpage>597</fpage>
          <lpage>619</lpage>
          <pub-id pub-id-type="pmid">23066376</pub-id>
        </element-citation>
      </ref>
      <ref id="b57-nss-9-081">
        <label>57</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Calero</surname>
              <given-names>G</given-names>
            </name>
            <name>
              <surname>Farre</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Ballester</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Hernandez</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>Daniel</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Montserrat Canal</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Physiological consequences of prolonged periods of flow limitation in patients with sleep apnea hypopnea syndrome</article-title>
          <source>Respir Med</source>
          <year>2006</year>
          <volume>100</volume>
          <issue>5</issue>
          <fpage>813</fpage>
          <lpage>817</lpage>
          <pub-id pub-id-type="pmid">16388943</pub-id>
        </element-citation>
      </ref>
      <ref id="b58-nss-9-081">
        <label>58</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Edinger</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Simmons</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Elz</surname>
              <given-names>K</given-names>
            </name>
            <name>
              <surname>Stock</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Pie</surname>
              <given-names>CA</given-names>
            </name>
          </person-group>
          <article-title>A pilot test of an online cognitive-behavioral insomnia therapy for patients with comorbid insomnia and sleep apnea</article-title>
          <source>Sleep</source>
          <year>2015</year>
          <volume>38</volume>
          <fpage>A236</fpage>
        </element-citation>
      </ref>
      <ref id="b59-nss-9-081">
        <label>59</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Anderson</surname>
              <given-names>KN</given-names>
            </name>
            <name>
              <surname>Goldsmith</surname>
              <given-names>P</given-names>
            </name>
            <name>
              <surname>Gardiner</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A pilot evaluation of an online cognitive behavioral therapy for insomnia disorder – targeted screening and interactive web design lead to improved sleep in a community population</article-title>
          <source>Nat Sci Sleep</source>
          <year>2014</year>
          <volume>6</volume>
          <fpage>43</fpage>
          <lpage>49</lpage>
          <pub-id pub-id-type="pmid">24669197</pub-id>
        </element-citation>
      </ref>
      <ref id="b60-nss-9-081">
        <label>60</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Crawford</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Turner</surname>
              <given-names>AD</given-names>
            </name>
            <name>
              <surname>Wyatt</surname>
              <given-names>JK</given-names>
            </name>
            <name>
              <surname>Fogg</surname>
              <given-names>LF</given-names>
            </name>
            <name>
              <surname>Ong</surname>
              <given-names>JC</given-names>
            </name>
          </person-group>
          <article-title>Evaluating the treatment of obstructive sleep apnea comorbid with insomnia disorder using an incomplete factorial design</article-title>
          <source>Contemp Clin Trials</source>
          <year>2015</year>
          <volume>47</volume>
          <fpage>146</fpage>
          <lpage>152</lpage>
          <pub-id pub-id-type="pmid">26733360</pub-id>
        </element-citation>
      </ref>
      <ref id="b61-nss-9-081">
        <label>61</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ong</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>MR</given-names>
            </name>
            <name>
              <surname>Kong</surname>
              <given-names>A</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Management of obstructive sleep apnea and comorbid insomnia: a mixed-methods evaluation</article-title>
          <source>Behav Sleep Med</source>
          <fpage>1</fpage>
          <lpage>18</lpage>
          <comment>Epub</comment>
          <year>2015</year>
          <month>12</month>
          <day>15</day>
          <pub-id pub-id-type="pmid">26619760</pub-id>
        </element-citation>
      </ref>
      <ref id="b62-nss-9-081">
        <label>62</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ong</surname>
              <given-names>JC</given-names>
            </name>
            <name>
              <surname>Crawford</surname>
              <given-names>MR</given-names>
            </name>
          </person-group>
          <article-title>Insomnia and obstructive sleep apnea</article-title>
          <source>Sleep Med Clin</source>
          <year>2013</year>
          <volume>8</volume>
          <issue>3</issue>
          <fpage>389</fpage>
          <lpage>398</lpage>
          <pub-id pub-id-type="pmid">24015117</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
  <floats-group>
    <fig id="f1-nss-9-081" position="float">
      <label>Figure 1</label>
      <caption>
        <p><citation_analysis attribute="neither">Flowchart of inclusion criteria and group definition.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> Data presented as mean (SD). </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither">Prescription given after a full night ASV or ABPAP titration PSG or split-therapy PSG where traditional PAP was failed early in the study allowing for subsequent titration with advanced PAP device. </citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="positive">Follow-up included appointments during which patients completed outcome questionnaires: ISI and ESS. </citation_analysis><citation_analysis attribute="positive"><sup>c</sup></citation_analysis><citation_analysis attribute="neither">Current PAP use defined by Objective Data Download or Subjective report. </citation_analysis><citation_analysis attribute="positive"><sup>d</sup></citation_analysis><citation_analysis attribute="neither">PAP users: PAP use ≥20 h/wk. </citation_analysis><citation_analysis attribute="positive"><sup>e</sup></citation_analysis><citation_analysis attribute="neither">Partial users: PAP use &lt;20 h/wk.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> ABPAP, autobilevel positive airway pressure; ASV, adaptive servoventilation; ESS, Epworth Sleepiness Scale; h, hours; ISI, insomnia severity index; N, nights; PAP, positive airway pressure; PSG, polysomnography; Rx, prescription; SDB, sleep disordered breathing; wk, week.</citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-9-081Fig1"/>
    </fig>
    <fig id="f2-nss-9-081" position="float">
      <label>Figure 2</label>
      <caption>
        <p><citation_analysis attribute="positive">Timing of subjective and objective PAP mode failure.</citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) Reasons for PAP failure following prescription from MSAS or other sleep laboratories. (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) Reasons for PAP failure during PSG desensitization. (</citation_analysis><citation_analysis attribute="positive"><bold>C</bold></citation_analysis><citation_analysis attribute="neither">) Reasons for PAP failure during technologist-attended titration PSG. Total number of reasons for failure at each time point exceeds sample size (n) due to multiple reasons for failure. Single-item reasons for failure in graphs (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) and (</citation_analysis><citation_analysis attribute="positive"><bold>C</bold></citation_analysis><citation_analysis attribute="neither">) exceed sample size (n) due to failure on multiple modes of PAP (CPAP, BPAP, and ABPAP). </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="positive">Subjective and objective reasons for PAP failure: emerging CSA: objective central-like pauses on airflow curve; pressure &gt;15: optimal pressures &gt;15 cmH</citation_analysis><citation_analysis attribute="positive"><sub>2</sub></citation_analysis><citation_analysis attribute="positive">O; aborted use: very limited or no use at home; subjective EPI: subjective intolerance to pressurized air (difficulty exhaling against PAP pressure); poor outcomes: persistently elevated ISI, fatigue, or daytime symptoms despite PAP therapy use; variable pressures: technologist observed need for variable pressures due to body position or sleep stage; residual SDB: persistent CSA, OSA, or UARS evident on data download or despite increases in PAP pressure; objective EPI: objective EPI on airflow waveform; and complex SA: presence of ≥5.0 central events/h (CAI) comprising &gt;50% of AHI events. </citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="positive">Prescribed device: patients who were prescribed a device and demonstrated subjective and objective PAP failure at home. </citation_analysis><citation_analysis attribute="positive"><sup>c</sup></citation_analysis><citation_analysis attribute="neither">Presleep/desensitization: PAP failure occurred either during a prestudy pressure desensitization the night of a titration or during daytime nap study used to gradually introduce PAP therapy to apprehensive patients (PAP-NAP). </citation_analysis><citation_analysis attribute="positive"><sup>d</sup></citation_analysis><citation_analysis attribute="neither">Titration: PAP failure occurred during a technologist-attended titration PSG in the sleep laboratory.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> ABPAP, autobilevel positive airway pressure; AHI, apnea–hypopnea index; BPAP, Bilevel PAP; CAI, Central Apnea Index; CPAP, continuous positive airway pressure; CSA, central sleep apnea; EPI, expiratory pressure intolerance; MSAS, Maimonides Sleep Arts &amp; Sciences; OSA, obstructive sleep apnea; PAP, positive airway pressure; PSG, polysomnography; SA, sleep apnea; SDB, sleep disordered breathing; UARS, upper airway resistance syndrome.</citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-9-081Fig2"/>
    </fig>
    <fig id="f3-nss-9-081" position="float">
      <label>Figure 3</label>
      <caption>
        <p><citation_analysis attribute="positive">Subjective symptoms for psychophysiological conditions and poor sleep hygiene reported at intake.</citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="positive">
</citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither">Items extracted from Intake Questionnaires. *Data from TMB-10, a questionnaire assessing time-monitoring behavior as it pertains to an individual’s insomnia.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="neither"> EtOH, alcohol; THC, marijuana TMB-10, Time Monitoring Behavior questionnaire.</citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-9-081Fig3"/>
    </fig>
    <fig id="f4-nss-9-081" position="float">
      <label>Figure 4</label>
      <caption>
        <p><citation_analysis attribute="neither">Within-group comparison of mean (SD) intake vs follow-up ISI values for (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) Total sample (n=302), (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) ASV sample (n=199), and (</citation_analysis><citation_analysis attribute="positive"><bold>C</bold></citation_analysis><citation_analysis attribute="neither">) ABPAP sample (n=103).</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> ABPAP, autobilevel positive airway pressure; ASV, adaptive servoventilation; ISI, insomnia severity index; PAP, positive airway pressure.</citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-9-081Fig4"/>
    </fig>
    <fig id="f5-nss-9-081" position="float">
      <label>Figure 5</label>
      <caption>
        <p><citation_analysis attribute="neither">Within-group comparison of mean intake vs follow-up values</citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither"> for 299</citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="neither"> patients on the following 3 ISI questions: SOI, SMI, and EMA.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="neither"> (</citation_analysis><citation_analysis attribute="positive"><bold>A</bold></citation_analysis><citation_analysis attribute="neither">) PAP users (n=243) vs partial users (n=56). (</citation_analysis><citation_analysis attribute="positive"><bold>B</bold></citation_analysis><citation_analysis attribute="neither">) ASV users (n=154) vs ASV partial users (n=43). (</citation_analysis><citation_analysis attribute="positive"><bold>C</bold></citation_analysis><citation_analysis attribute="neither">) ABPAP users (n=89) vs ABPAP partial users (n=13). </citation_analysis><citation_analysis attribute="positive"><sup>a</sup></citation_analysis><citation_analysis attribute="neither">Cohen’s </citation_analysis><citation_analysis attribute="positive"><italic>d</italic></citation_analysis><citation_analysis attribute="positive"> reported above each follow-up average. </citation_analysis><citation_analysis attribute="positive"><sup>b</sup></citation_analysis><citation_analysis attribute="neither">Individual ISI responses were unavailable for 3 subjects. *</citation_analysis><citation_analysis attribute="positive"><italic>P</italic></citation_analysis><citation_analysis attribute="neither">=0.001.</citation_analysis></p>
        <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> ABPAP, autobilevel positive airway pressure; ASV, adaptive servoventilation; EMA, early morning awakenings; ISI, insomnia severity index; PAP, positive airway pressure; SMI, sleep maintenance insomnia; SOI, sleep onset insomnia.</citation_analysis></p>
      </caption>
      <graphic xlink:href="nss-9-081Fig5"/>
    </fig>
    <table-wrap id="t1-nss-9-081" position="float">
      <label>Table 1</label>
      <caption>
        <p><citation_analysis attribute="neither">Prior research investigations on the impact of sleep-disordered breathing treatments on chronic insomnia severity</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table-fn" rid="tfn1-nss-9-081">a</xref></citation_analysis></p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="top" align="left" rowspan="1" colspan="1">Author(s), study type</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Level of evidence<xref ref-type="table-fn" rid="tfn2-nss-9-081">b</xref></th>
            <th valign="top" align="left" rowspan="1" colspan="1">Treatment sample (n)</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Treatment type(s)</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Control group (Y/N), type of control</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Insomnia measure<xref ref-type="table-fn" rid="tfn3-nss-9-081">c</xref></th>
            <th valign="top" align="left" rowspan="1" colspan="1">Time to follow-up</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Notes on insomnia data</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Krakow et al,<xref rid="b36-nss-9-081" ref-type="bibr">36</xref> prospective study</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">14</td>
            <td valign="top" align="left" rowspan="1" colspan="1">PAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(Y), no SDB treatment</td>
            <td valign="top" align="left" rowspan="1" colspan="1">SSQ</td>
            <td valign="top" align="left" rowspan="1" colspan="1">20.6 mo</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Thirteen of the 14 patients (92.9%) in treatment group subjectively reported better sleep quality after treatment compared to 3 of 9 (33.3%) in control group (Fisher statistic =8.69; <italic>P</italic>=0.005)</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Guilleminault et al,<xref rid="b22-nss-9-081" ref-type="bibr">22</xref>,<xref rid="b34-nss-9-081" ref-type="bibr">34</xref> comparative controlled study</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">62</td>
            <td valign="top" align="left" rowspan="1" colspan="1">ENT, PAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(Y), no SDB</td>
            <td valign="top" align="left" rowspan="1" colspan="1">SOL</td>
            <td valign="top" align="left" rowspan="1" colspan="1">6 mo</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Limited quantitative data published but authors reported improvements in objective SOL and WASO in UARS patients treated with radiofrequency ablation or PAP therapy</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Krakow et al,<xref rid="b37-nss-9-081" ref-type="bibr">37</xref> retrospective chart review (part 1)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4</td>
            <td valign="top" align="left" rowspan="1" colspan="1">19</td>
            <td valign="top" align="left" rowspan="1" colspan="1">PAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(N)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">SOL</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1">Significant decrease in objective SOL (<italic>P</italic>=0.04; <italic>d</italic>=0.49) with the use of PAP</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Krakow et al,<xref rid="b37-nss-9-081" ref-type="bibr">37</xref> prospective cross-over study (part 2)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">17</td>
            <td valign="top" align="left" rowspan="1" colspan="1">CBT, PAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(Y), patients served as own CBT vs PAP control</td>
            <td valign="top" align="left" rowspan="1" colspan="1">ISI</td>
            <td valign="top" align="left" rowspan="1" colspan="1">3 mo</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Large improvement for ISI from baseline to CBT follow-up (<italic>F</italic>[1,16]=17.58, <italic>P</italic>=0.001, <italic>d</italic>=1.53) and highly significant effects from CBT follow-up to PAP follow-up at the end of study (<italic>F</italic>[1,16]=12.09, <italic>P</italic>=0.003, <italic>d</italic>=1.11)</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Krakow et al,<xref rid="b38-nss-9-081" ref-type="bibr">38</xref> randomized controlled trial</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">42</td>
            <td valign="top" align="left" rowspan="1" colspan="1">NDS</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(Y), nontreatment</td>
            <td valign="top" align="left" rowspan="1" colspan="1">ISI, SOL, TST, WAKE</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4 wk</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Significant improvement in ISI (<italic>P</italic>=0.0001; <italic>d</italic>=1.20), subjective TST (<italic>P</italic>=0.02), and subjective number of awakenings (<italic>P</italic>=0.05) in nasal dilator strip users vs controls</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Guilleminault et al,<xref rid="b35-nss-9-081" ref-type="bibr">35</xref> prospective crossover study</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">25</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Surgery</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(Y), CBT-I only</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TST, WASO</td>
            <td valign="top" align="left" rowspan="1" colspan="1">3 mo</td>
            <td valign="top" align="left" rowspan="1" colspan="1">TST increased from 6.24 h/night at baseline to 6.75 h/night after SDB treatment (<italic>P</italic>=0.0001). WASO decreased from 45.4 min at baseline to 8.4 min after SDB treatment (<italic>P</italic>=0.0001)</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Nguyen et al,<xref rid="b40-nss-9-081" ref-type="bibr">40</xref> prospective and observational study</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">80</td>
            <td valign="top" align="left" rowspan="1" colspan="1">APAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(Y), PAP discontinuers</td>
            <td valign="top" align="left" rowspan="1" colspan="1">ISI</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2 years</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Mean ISI [SD] decreased significantly (13.7 [5.7] vs 8.2 [6.3]; <italic>P</italic>=0.0001) from baseline to 2 years follow-up. Of the 39 patients with ISI &gt;15 at baseline, 20 (51%) had an ISI decrease of ≥9 at the 2-year follow-up</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Krakow et al,<xref rid="b39-nss-9-081" ref-type="bibr">39</xref> retrospective chart review</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4</td>
            <td valign="top" align="left" rowspan="1" colspan="1">56</td>
            <td valign="top" align="left" rowspan="1" colspan="1">ASV</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(N)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">SE, WASO, WAKE, ARSL, ISI</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1.3 years</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Significant improvement in objective SE (<italic>P</italic>&lt;0.001; <italic>d</italic>=0.71), WASO (<italic>P</italic>&lt;0.05; <italic>d</italic>=0.40), total awakenings index (<italic>P</italic>&lt;0.01; <italic>d</italic>=0.49), and total arousals index (<italic>P</italic>&lt;0.05; <italic>d</italic>=0.44) when using ASV vs traditional PAP. Outcomes data available for 39 of the 56 patients showed a significant improvement in ISI score (16.8 vs 9.7; <italic>P</italic>=0.001; <italic>d</italic>=1.40).</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Bjornsdottir et al,<xref rid="b32-nss-9-081" ref-type="bibr">32</xref> longitudinal cohort study</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2b</td>
            <td valign="top" align="left" rowspan="1" colspan="1">473</td>
            <td valign="top" align="left" rowspan="1" colspan="1">PAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(N)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">BNSQ</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2 years</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Symptoms of sleep maintenance insomnia were most common at baseline and improved significantly (<italic>P</italic>&lt;0.001) among patients using PAP</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Glidewell et al,<xref rid="b33-nss-9-081" ref-type="bibr">33</xref> retrospective chart review</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4</td>
            <td valign="top" align="left" rowspan="1" colspan="1">53</td>
            <td valign="top" align="left" rowspan="1" colspan="1">PAP</td>
            <td valign="top" align="left" rowspan="1" colspan="1">(N)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">ISI</td>
            <td valign="top" align="left" rowspan="1" colspan="1">43</td>
            <td valign="top" align="left" rowspan="1" colspan="1">Twenty-four of the 53 (45%) patients with moderate-to-severe insomnia at baseline reported no/mild insomnia symptoms after PAP therapy. The remaining 55% had persistent moderate-to-severe insomnia but had significantly higher pretreatment ISI scores (<italic>P</italic>&lt;0.001), lower RDI (<italic>P</italic>=0.01), and lower PAP use (<italic>P</italic>=0.04)</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><citation_analysis attribute="positive">
            </citation_analysis><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="positive">
          </citation_analysis></p>
        </fn>
        <fn id="tfn1-nss-9-081">
          <label>a</label>
          <p><citation_analysis attribute="positive">Change in outcomes reported as direct result of PAP use.</citation_analysis></p>
        </fn>
        <fn id="tfn2-nss-9-081">
          <label>b</label>
          <p><citation_analysis attribute="positive">Level of evidence based on Sackett’s criteria.</citation_analysis></p>
        </fn>
        <fn id="tfn3-nss-9-081">
          <label>c</label>
          <p><citation_analysis attribute="positive">Measurements included in each outcomes category: ↓ objective sleepiness, MSLT; ↓ subjective sleepiness, ESS, FOSQ-10, and FOSQ.</citation_analysis></p>
        </fn>
        <fn id="tfn4-nss-9-081">
          <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> APAP, automatic continuous PAP; ARSL, total objective arousals; ASV, adaptive servoventilation; BNSQ, Basic Nordic Sleep Questionnaire; CBT, cognitive behavioral therapy; CBT-I, CBT for insomnia; ENT, ear nose and throat doctor; ESS, Epworth Sleepiness Scale; FOSQ, Functional Outcomes of Sleep Questionnaire; FOSQ-10, Functional Outcomes of Sleep Questionnaire Short Form; ISI, insomnia severity index; MSLT, Multiple Sleep Latency Test; N, no; NDS, nasal dilator strip; PAP, positive airway pressure; RDI, respiratory disturbance index; SDB, sleep disordered breathing; SE, sleep efficiency; SOL, objective sleep onset latency; SSQ, subjective sleep quality; TST, total sleep time; UARS, upper airway resistance syndrome; WAKE, objective total awakenings; WASO, objective wake after sleep onset; Y, yes.</citation_analysis></p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
    <table-wrap id="t2-nss-9-081" position="float">
      <label>Table 2</label>
      <caption>
        <p><citation_analysis attribute="positive">Sociodemographics, psychiatric history, and baseline subjective sleep and objective respiratory indices for PAP users vs partial users</citation_analysis><citation_analysis attribute="positive"><xref ref-type="table-fn" rid="tfn5-nss-9-081">a</xref></citation_analysis></p>
      </caption>
      <table frame="hsides" rules="groups">
        <thead>
          <tr>
            <th valign="top" align="left" rowspan="1" colspan="1">Variable</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Total sample<break/>(n=302)</th>
            <th valign="top" align="left" rowspan="1" colspan="1">PAP users<break/>(n=246)</th>
            <th valign="top" align="left" rowspan="1" colspan="1">Partial users<break/>(n=56)</th>
            <th valign="top" align="left" rowspan="1" colspan="1">PAP users vs partial users<break/>(<italic>P</italic>-value; Hedge’s <italic>g</italic><xref ref-type="table-fn" rid="tfn6-nss-9-081">b</xref>)</th>
          </tr>
        </thead>
        <tbody>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Sociodemographics</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Sex</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Male</td>
            <td valign="top" align="left" rowspan="1" colspan="1">168 (55.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">137 (55.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">31 (55.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.54</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Female</td>
            <td valign="top" align="left" rowspan="1" colspan="1">134 (44.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">109 (44.3%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">25 (44.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.54</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Ethnicity</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Caucasian</td>
            <td valign="top" align="left" rowspan="1" colspan="1">187 (61.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">158 (64.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">29 (51.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.09</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Hispanic</td>
            <td valign="top" align="left" rowspan="1" colspan="1">85 (28.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">65 (26.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">20 (35.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.19</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Other<xref ref-type="table-fn" rid="tfn7-nss-9-081">c</xref></td>
            <td valign="top" align="left" rowspan="1" colspan="1">30 (9.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">23 (9.34%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">7 (12.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.46</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Marital status</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Married/living with partner</td>
            <td valign="top" align="left" rowspan="1" colspan="1">203 (67.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">168 (68.3%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">35 (62.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.25</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Single/divorced</td>
            <td valign="top" align="left" rowspan="1" colspan="1">99 (32.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">78 (31.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">21 (37.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.25</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Education level completed</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Bachelor’s degree or higher</td>
            <td valign="top" align="left" rowspan="1" colspan="1">145 (48.0%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">116 (47.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">29 (51.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.32</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  Some college or less</td>
            <td valign="top" align="left" rowspan="1" colspan="1">157 (52.0%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">130 (52.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">27 (48.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.32</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Age, years</td>
            <td valign="top" align="left" rowspan="1" colspan="1">53.44 (14.21)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">53.34 (14.07)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">53.84 (14.94)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.81; 0.04</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">BMI (kg/m<sup>2</sup>)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">31.59 (8.00)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">31.92 (7.87)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">30.17 (8.50)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.14; 0.22</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Insomnia chronicity, years<xref ref-type="table-fn" rid="tfn8-nss-9-081">d</xref></td>
            <td valign="top" align="left" rowspan="1" colspan="1">10.28 (7.33)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10.35 (7.26)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">9.94 (7.73)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.71; 0.06</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ISI score</td>
            <td valign="top" align="left" rowspan="1" colspan="1">19.11 (3.34)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">19.02 (3.23)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">19.52 (3.79)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.31; 0.15</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">ESS score</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10.89 (6.02)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10.84 (6.06)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">11.11 (5.90)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.76; 0.04</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Prescription sleep aid use</td>
            <td valign="top" align="left" rowspan="1" colspan="1">127 (42.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">100 (40.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">27 (48.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.19</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">OTC sleep aid use</td>
            <td valign="top" align="left" rowspan="1" colspan="1">85 (28.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">72 (29.3%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">13 (23.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.23</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Psychiatric history</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Anxiety</td>
            <td valign="top" align="left" rowspan="1" colspan="1">99 (32.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">78 (31.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">21 (37.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.25</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Depression</td>
            <td valign="top" align="left" rowspan="1" colspan="1">149 (49.3%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">120 (48.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">29 (51.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.39</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> PTSD</td>
            <td valign="top" align="left" rowspan="1" colspan="1">37 (12.3%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">32 (13.0%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5 (8.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.28</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Panic attacks</td>
            <td valign="top" align="left" rowspan="1" colspan="1">61 (20.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">46 (18.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15 (26.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.12</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Bipolar disorder</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15 (5.0%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">14 (5.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1 (1.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.20</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> OCD</td>
            <td valign="top" align="left" rowspan="1" colspan="1">20 (6.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">15 (6.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5 (8.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.30</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Other<xref ref-type="table-fn" rid="tfn9-nss-9-081">e</xref></td>
            <td valign="top" align="left" rowspan="1" colspan="1">13 (4.3%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">9 (3.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">4 (7.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.21</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Trauma history</td>
            <td valign="top" align="left" rowspan="1" colspan="1">92 (30.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">76 (30.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">16 (28.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.43</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Claustrophobia</td>
            <td valign="top" align="left" rowspan="1" colspan="1">84 (27.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">68 (27.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">16 (28.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.50</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> None</td>
            <td valign="top" align="left" rowspan="1" colspan="1">75 (24.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">65 (26.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10 (17.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.12</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Medical history<xref ref-type="table-fn" rid="tfn10-nss-9-081">f</xref></td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Arthritis/pain</td>
            <td valign="top" align="left" rowspan="1" colspan="1">116 (38.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">95 (38.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">21 (37.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1.0</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Cardiac</td>
            <td valign="top" align="left" rowspan="1" colspan="1">48 (15.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">38 (15.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">10 (17.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.67</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Drug/alcohol abuse</td>
            <td valign="top" align="left" rowspan="1" colspan="1">21 (7.0%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">14 (5.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">7 (12.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.08</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Endocrine</td>
            <td valign="top" align="left" rowspan="1" colspan="1">162 (53.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">132 (53.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">30 (53.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1.0</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Hypertension</td>
            <td valign="top" align="left" rowspan="1" colspan="1">133 (37.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">106 (43.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">27 (48.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.55</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Kidney</td>
            <td valign="top" align="left" rowspan="1" colspan="1">63 (20.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">52 (21.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">11 (19.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1.0</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Neurologic</td>
            <td valign="top" align="left" rowspan="1" colspan="1">74 (24.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">60 (24.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">14 (25.0%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1.0</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Pulmonary</td>
            <td valign="top" align="left" rowspan="1" colspan="1">249 (82.5%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">202 (82.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">47 (83.9%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.85</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Reflux</td>
            <td valign="top" align="left" rowspan="1" colspan="1">115 (38.1%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">89 (36.2%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">26 (46.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.17</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Subjective sleep indices</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> TIB, h</td>
            <td valign="top" align="left" rowspan="1" colspan="1">7.98 (1.60)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">8.08 (1.51)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">7.54 (1.88)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.020; 0.34</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> TST, h</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5.91 (1.71)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">6.02 (1.69)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">5.41 (1.70)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.015; 0.36</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> SE, %</td>
            <td valign="top" align="left" rowspan="1" colspan="1">75.14 (19.25)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">75.68 (19.28)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">72.76 (19.13)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.31; 0.15</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> SOL, min</td>
            <td valign="top" align="left" rowspan="1" colspan="1">64.56 (63.08)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">62.10 (60.19)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">75.34 (74.15)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.16; 0.21</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> WASO, min</td>
            <td valign="top" align="left" rowspan="1" colspan="1">110.56 (97.08)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">109.21 (95.67)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">116.52 (103.73)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.61; 0.08</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">Objective respiratory indices</td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> AHI<xref ref-type="table-fn" rid="tfn11-nss-9-081">g</xref>, events/h</td>
            <td valign="top" align="left" rowspan="1" colspan="1">32.02 (28.17)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">31.16 (27.93)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">35.64 (29.17)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.28; 0.16</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> RDI<xref ref-type="table-fn" rid="tfn12-nss-9-081">h</xref>, events/h</td>
            <td valign="top" align="left" rowspan="1" colspan="1">60.26 (29.66)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">60.27 (28.70)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">60.24 (33.69)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">1.00; 0.00</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1"> Diagnosis<xref ref-type="table-fn" rid="tfn13-nss-9-081">i</xref></td>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
            <td valign="top" align="left" rowspan="1" colspan="1"/>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  OSA</td>
            <td valign="top" align="left" rowspan="1" colspan="1">274 (90.7%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">220 (89.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">54 (96.4%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.047</td>
          </tr>
          <tr>
            <td valign="top" align="left" rowspan="1" colspan="1">  UARS</td>
            <td valign="top" align="left" rowspan="1" colspan="1">28 (9.8%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">26 (10.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">2 (3.6%)</td>
            <td valign="top" align="left" rowspan="1" colspan="1">0.076</td>
          </tr>
        </tbody>
      </table>
      <table-wrap-foot>
        <fn>
          <p><citation_analysis attribute="positive">
            </citation_analysis><citation_analysis attribute="positive"><bold>Notes:</bold></citation_analysis><citation_analysis attribute="positive">
          </citation_analysis></p>
        </fn>
        <fn id="tfn5-nss-9-081">
          <label>a</label>
          <p><citation_analysis attribute="neither">PAP users: ≥20 h/wk; partial users: &lt;20 h/wk.</citation_analysis></p>
        </fn>
        <fn id="tfn6-nss-9-081">
          <label>b</label>
          <p><citation_analysis attribute="neither">Hedge’s </citation_analysis><citation_analysis attribute="positive"><italic>g</italic></citation_analysis><citation_analysis attribute="neither"> used to determine effect size between unequal samples sizes for continuous variables.</citation_analysis></p>
        </fn>
        <fn id="tfn7-nss-9-081">
          <label>c</label>
          <p><citation_analysis attribute="neither">Other: unspecified, n=10; Asian American, n=7; African American, n=5; Hispanic/Caucasian, n=3; Native American, n=3; Indian, n=1; Middle Eastern, n=1.</citation_analysis></p>
        </fn>
        <fn id="tfn8-nss-9-081">
          <label>d</label>
          <p><citation_analysis attribute="positive">Fifteen patients did not report duration for their insomnia, average was calculated using 287.</citation_analysis></p>
        </fn>
        <fn id="tfn9-nss-9-081">
          <label>e</label>
          <p><citation_analysis attribute="neither">Other: ADD/ADHD, n=5; addiction, n=5; memory loss, n=2; agoraphobic, n=1.</citation_analysis></p>
        </fn>
        <fn id="tfn10-nss-9-081">
          <label>f</label>
          <p><citation_analysis attribute="positive">Medical history: number of patients identifying at least one comorbidity per category. Of the 302 patients, 292 patients reported at least one medical comorbidity with an average of &gt;5 comorbidities per patient. Medical co-morbidities were organized into specific categories.</citation_analysis></p>
        </fn>
        <fn id="tfn11-nss-9-081">
          <label>g</label>
          <p><citation_analysis attribute="neither">AHI available for 292 of the 302 patients, 236/246 PAP users and 56/56 partial users.</citation_analysis></p>
        </fn>
        <fn id="tfn12-nss-9-081">
          <label>h</label>
          <p><citation_analysis attribute="neither">RDI available for 265 of the 302 patients, 214/246 PAP users and 51/56 partial users.</citation_analysis></p>
        </fn>
        <fn id="tfn13-nss-9-081">
          <label>i</label>
          <p><citation_analysis attribute="positive">AHI was unavailable for 10 patients previously diagnosed with OSA with no obtainable records or no reported AHI; RDI was unavailable for 37 patients previously diagnosed with OSA with no obtainable records or no reported RDI.</citation_analysis></p>
        </fn>
        <fn id="tfn14-nss-9-081">
          <p><citation_analysis attribute="positive"><bold>Abbreviations:</bold></citation_analysis><citation_analysis attribute="positive"> AHI, apnea–hypopnea index; BMI, body mass index; ESS, Epworth Sleepiness Scale; ISI, insomnia severity index; OCD, obsessive compulsive disorder; OSA, obstructive sleep apnea; OTC, over the counter; PAP, positive airway pressure; PTSD, post-traumatic stress disorder; RDI, respiratory disturbance index; SE, sleep efficiency; SOL, sleep onset latency; TIB, time in bed; TST, total sleep time; UARS, upper airway resistance syndrome; WASO, wake after sleep onset.</citation_analysis></p>
        </fn>
      </table-wrap-foot>
    </table-wrap>
  </floats-group>
</article>
</pmc-articleset>
